LOKIASV2_0185_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A	5u94-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PASTA kinase PknB in complex with the potential theraputic kinase inhibitor GSK690693.	1.886E-17	1.000	575	11	295	443	4	262	263	295	0.643	0.985
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2p-assembly1.cif.gz_A-2	6b2p-assembly1.cif.gz_A-2 Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	1.571E-16	1.000	549	12	295	443	4	254	255	293	0.641	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A	1o6y-assembly1.cif.gz_A Catalytic domain of PknB kinase from Mycobacterium tuberculosis	2.857E-16	1.000	546	5	294	443	1	258	260	298	0.655	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A	1mru-assembly1.cif.gz_A Intracellular Ser/Thr protein kinase domain of Mycobacterium tuberculosis PknB.	3.185E-16	1.000	515	13	297	443	7	262	269	293	0.643	0.952
LOKIASV2_0185_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D	3ori-assembly4.cif.gz_D Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 1)	5.195E-16	1.000	504	16	297	443	2	256	267	291	0.637	0.955
LOKIASV2_0185_ESMFold_hypothetical_protein	3ort-assembly1.cif.gz_A	3ort-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 6)	7.198E-16	1.000	502	3	297	443	1	261	271	303	0.666	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	3orm-assembly1.cif.gz_A	3orm-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain D76A mutant	7.198E-16	1.000	495	16	297	443	2	256	266	290	0.637	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	2fum-assembly3.cif.gz_C	2fum-assembly3.cif.gz_C Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	3.882E-15	1.000	492	12	294	443	5	252	254	293	0.639	0.976
LOKIASV2_0185_ESMFold_hypothetical_protein	3orp-assembly1.cif.gz_A	3orp-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 5)	2.022E-15	1.000	492	3	297	443	1	263	274	303	0.666	0.960
LOKIASV2_0185_ESMFold_hypothetical_protein	2fum-assembly4.cif.gz_D	2fum-assembly4.cif.gz_D Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	3.676E-15	1.000	489	12	294	443	5	257	258	292	0.639	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A	3oro-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 4)	1.174E-15	1.000	482	16	297	443	3	263	272	290	0.637	0.960
LOKIASV2_0185_ESMFold_hypothetical_protein	3f61-assembly1.cif.gz_A	3f61-assembly1.cif.gz_A Crystal Structure of M. tuberculosis PknB Leu33Asp/Val222Asp double mutant in complex with ADP	9.974E-16	1.000	480	13	297	443	9	260	271	294	0.643	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	1.382E-15	1.000	478	1	298	443	1	280	280	308	0.673	1.000
LOKIASV2_0185_ESMFold_hypothetical_protein	6i2p-assembly1.cif.gz_A	6i2p-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	6.817E-16	1.000	475	1	295	443	2	271	272	304	0.666	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A	3f69-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	3.676E-15	1.000	474	5	297	443	1	262	270	301	0.661	0.970
LOKIASV2_0185_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	1.541E-15	1.000	470	16	298	443	14	285	285	296	0.639	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	6i2p-assembly2.cif.gz_B	6i2p-assembly2.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	1.718E-15	1.000	467	12	294	443	6	265	266	293	0.639	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A	3orl-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 3)	3.882E-15	1.000	463	5	297	443	1	258	268	302	0.661	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	1.718E-15	1.000	463	1	296	443	1	277	279	309	0.668	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	3ork-assembly1.cif.gz_A	3ork-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 2)	5.094E-15	1.000	461	4	297	443	4	263	274	303	0.664	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A	6b2q-assembly1.cif.gz_A Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	1.258E-13	1.000	458	4	299	443	1	257	262	302	0.668	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C	4eqm-assembly3.cif.gz_C Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	3.234E-14	1.000	455	9	299	443	4	262	269	303	0.657	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D	4j95-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	2.747E-14	1.000	446	1	296	443	1	269	271	308	0.668	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	7.058E-15	1.000	446	1	298	443	1	271	271	311	0.673	1.000
LOKIASV2_0185_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_B	3f69-assembly1.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	2.900E-14	1.000	445	4	297	443	1	275	283	303	0.664	0.972
LOKIASV2_0185_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B	5m06-assembly1.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain	4.731E-14	1.000	441	3	293	443	1	246	248	295	0.657	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	1.216E-14	1.000	441	16	298	443	15	275	276	296	0.639	0.946
LOKIASV2_0185_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	1.033E-14	1.000	441	3	298	443	5	281	281	309	0.668	0.986
LOKIASV2_0185_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	1.431E-14	1.000	440	1	296	443	9	285	288	308	0.668	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	8.147E-14	1.000	439	4	297	443	1	258	265	301	0.664	0.974
LOKIASV2_0185_ESMFold_hypothetical_protein	3bgz-assembly1.cif.gz_A	3bgz-assembly1.cif.gz_A Human Pim-1 kinase in complex with diphenyl indole inhibitor VX3	3.806E-14	1.000	438	16	295	443	6	267	268	297	0.632	0.978
LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C	6agx-assembly2.cif.gz_C The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	1.595E-14	1.000	437	1	298	443	1	284	284	314	0.673	1.000
LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	1.033E-14	1.000	437	3	298	443	3	285	285	313	0.668	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	4enx-assembly1.cif.gz_A	4enx-assembly1.cif.gz_A Crystal Structure of Pim-1 Kinase in complex with inhibitor (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4-one	1.192E-13	1.000	433	16	298	443	2	253	266	290	0.639	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	4lm5-assembly1.cif.gz_A	4lm5-assembly1.cif.gz_A Crystal structure of Pim1 in complex with 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol (resulting from displacement of SKF86002)	1.564E-13	1.000	432	16	298	443	4	252	265	287	0.639	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	3kxx-assembly1.cif.gz_A	3kxx-assembly1.cif.gz_A Structure of the mutant Fibroblast Growth Factor receptor 1	4.099E-15	1.000	431	1	299	443	4	304	305	326	0.675	0.987
LOKIASV2_0185_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	3.605E-14	1.000	430	3	296	443	7	287	292	307	0.664	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	2.551E-13	1.000	428	16	297	443	8	267	269	291	0.637	0.967
LOKIASV2_0185_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A	5n5l-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and [2-oxo-2-(1H-pyrrol-2-yl)ethyl] 5-bromo-1H-indole-3-carboxylate	6.208E-14	1.000	428	16	298	443	6	259	272	296	0.639	0.934
LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly2.cif.gz_B	4x3f-assembly2.cif.gz_B Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	1.744E-13	1.000	427	3	299	443	1	270	280	308	0.670	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	2.747E-14	1.000	426	3	296	443	9	297	301	315	0.664	0.960
LOKIASV2_0185_ESMFold_hypothetical_protein	3cxw-assembly1.cif.gz_A	3cxw-assembly1.cif.gz_A Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I	8.147E-14	1.000	425	16	298	443	6	258	272	296	0.639	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	2.416E-13	1.000	424	13	297	443	9	260	267	295	0.643	0.944
LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A	4j97-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	5.880E-14	1.000	424	3	296	443	2	280	282	308	0.664	0.989
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	3.063E-14	1.000	424	16	298	443	16	285	286	297	0.639	0.944
LOKIASV2_0185_ESMFold_hypothetical_protein	6l14-assembly1.cif.gz_A	6l14-assembly1.cif.gz_A Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives	6.921E-14	1.000	422	16	295	443	6	270	271	304	0.632	0.978
LOKIASV2_0185_ESMFold_hypothetical_protein	4alu-assembly1.cif.gz_A	4alu-assembly1.cif.gz_A Benzofuropyrimidinone Inhibitors of Pim-1	1.258E-13	1.000	422	16	298	443	6	260	274	294	0.639	0.931
LOKIASV2_0185_ESMFold_hypothetical_protein	2bil-assembly1.cif.gz_B	2bil-assembly1.cif.gz_B The human protein kinase Pim1 in complex with its consensus peptide Pimtide	1.192E-13	1.000	422	16	298	443	6	260	274	297	0.639	0.931
LOKIASV2_0185_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	2.602E-14	1.000	422	3	296	443	8	301	305	319	0.664	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_C-2	4j97-assembly5.cif.gz_C-2 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	2.167E-13	1.000	421	1	296	443	1	281	283	309	0.668	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	2c3i-assembly1.cif.gz_B	2c3i-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I	1.329E-13	1.000	419	16	295	443	2	265	266	301	0.632	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	1.744E-13	1.000	418	16	298	443	7	267	268	294	0.639	0.974
LOKIASV2_0185_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	9.083E-14	1.000	417	1	298	443	1	287	287	317	0.673	1.000
LOKIASV2_0185_ESMFold_hypothetical_protein	5m07-assembly1.cif.gz_A	5m07-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	3.941E-13	1.000	416	2	293	443	1	245	248	295	0.659	0.988
LOKIASV2_0185_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A	5m06-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain	4.639E-13	1.000	415	2	293	443	1	243	245	294	0.659	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D	6agx-assembly2.cif.gz_D The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	2.900E-14	1.000	415	3	298	443	3	298	298	321	0.668	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A	7kie-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3	6.555E-14	1.000	414	3	296	443	4	287	291	311	0.664	0.976
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_B	6v6q-assembly1.cif.gz_B Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	4.731E-14	1.000	414	16	296	443	15	287	291	299	0.634	0.938
LOKIASV2_0185_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	2.551E-13	1.000	413	5	310	443	1	289	293	319	0.691	0.986
LOKIASV2_0185_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	1.234E-12	1.000	412	13	295	443	6	265	266	292	0.639	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	3vbt-assembly1.cif.gz_A	3vbt-assembly1.cif.gz_A Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design	4.393E-13	1.000	412	16	298	443	4	254	267	291	0.639	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	5toe-assembly1.cif.gz_A	5toe-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	1.564E-13	1.000	411	16	296	443	5	271	272	302	0.634	0.982
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_D	6b2q-assembly1.cif.gz_D Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	8.906E-13	1.000	410	4	297	443	1	254	260	302	0.664	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A	1ql6-assembly1.cif.gz_A THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES	7.566E-13	1.000	409	16	298	443	9	279	281	302	0.639	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B	5ugx-assembly1.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	5.880E-14	1.000	409	3	298	443	2	282	282	317	0.668	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B	5m07-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	4.393E-13	1.000	408	2	293	443	1	244	247	297	0.659	0.988
LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B	5vja-assembly1.cif.gz_B Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	8.906E-13	1.000	408	13	297	443	5	264	266	296	0.643	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F	4eqm-assembly6.cif.gz_F Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	3.348E-13	1.000	408	16	301	443	10	262	268	297	0.646	0.944
LOKIASV2_0185_ESMFold_hypothetical_protein	7uir-assembly2.cif.gz_B	7uir-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1 in complex with ATP	9.929E-13	1.000	407	10	298	443	1	261	261	300	0.652	1.000
LOKIASV2_0185_ESMFold_hypothetical_protein	7khk-assembly1.cif.gz_A	7khk-assembly1.cif.gz_A Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX9486 (bezuclastinib) in the DFG-in state	3.171E-13	1.000	407	1	296	443	3	289	291	316	0.668	0.986
LOKIASV2_0185_ESMFold_hypothetical_protein	1yxs-assembly1.cif.gz_A	1yxs-assembly1.cif.gz_A Crystal Structure of Kinase Pim1 with P123M mutation	3.171E-13	1.000	406	16	296	443	6	273	274	303	0.634	0.978
LOKIASV2_0185_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2	4ow8-assembly1.cif.gz_A-2 Crystal structure of kinase domain of PknA from Mtb	7.989E-13	1.000	406	4	297	443	1	270	276	302	0.664	0.978
LOKIASV2_0185_ESMFold_hypothetical_protein	6aar-assembly1.cif.gz_A	6aar-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with purpurin	2.369E-12	1.000	405	16	290	443	12	264	269	289	0.621	0.941
LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_D	5vja-assembly1.cif.gz_D Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	1.107E-12	1.000	403	13	297	443	5	260	261	293	0.643	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	4.639E-13	1.000	403	16	298	443	15	284	284	301	0.639	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	6.088E-13	1.000	403	16	300	443	7	269	294	294	0.643	0.895
LOKIASV2_0185_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B	5m09-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136N double mutant	1.303E-12	1.000	402	3	293	443	1	242	245	293	0.657	0.988
LOKIASV2_0185_ESMFold_hypothetical_protein	8ie5-assembly1.cif.gz_A	8ie5-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with oxyresveratrol	2.369E-12	1.000	402	16	296	443	12	269	271	295	0.634	0.952
LOKIASV2_0185_ESMFold_hypothetical_protein	6vzk-assembly1.cif.gz_A	6vzk-assembly1.cif.gz_A Crystal structure of human CaMKII-alpha (CAMK2A)kinase domain	1.234E-12	1.000	400	16	297	443	7	256	258	292	0.637	0.969
LOKIASV2_0185_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B	7b57-assembly1.cif.gz_B Crystal structure of CaMKII-actinin complex bound to ADP	6.088E-13	1.000	400	16	300	443	9	271	303	295	0.643	0.868
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	7.566E-13	1.000	400	16	300	443	2	264	459	294	0.643	0.573
LOKIASV2_0185_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B	5m08-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	4.393E-13	1.000	399	2	295	443	1	252	253	305	0.664	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	2v7a-assembly1.cif.gz_A	2v7a-assembly1.cif.gz_A Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358	2.167E-13	1.000	399	16	297	443	10	267	270	291	0.637	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	1.652E-13	1.000	399	13	304	443	6	273	284	303	0.659	0.944
LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly1.cif.gz_A	4x3f-assembly1.cif.gz_A Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	8.906E-13	1.000	398	6	299	443	1	267	277	307	0.664	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_B	2py3-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	3.941E-13	1.000	398	3	296	443	2	280	284	310	0.664	0.982
LOKIASV2_0185_ESMFold_hypothetical_protein	5k3y-assembly2.cif.gz_B	5k3y-assembly2.cif.gz_B Crystal structure of AuroraB/INCENP in complex with BI 811283	6.428E-13	1.000	397	1	298	443	1	268	278	302	0.673	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C	6v6q-assembly2.cif.gz_C Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	3.171E-13	1.000	397	16	296	443	15	275	279	297	0.634	0.935
LOKIASV2_0185_ESMFold_hypothetical_protein	2vgo-assembly2.cif.gz_B	2vgo-assembly2.cif.gz_B Crystal structure of Aurora B kinase in complex with Reversine inhibitor	7.566E-13	1.000	396	2	298	443	3	267	278	301	0.670	0.953
LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_C	5vja-assembly1.cif.gz_C Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	2.244E-12	1.000	395	13	297	443	5	263	265	296	0.643	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2	2phk-assembly1.cif.gz_A-2 THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION	2.013E-12	1.000	395	16	296	443	6	274	277	300	0.634	0.971
LOKIASV2_0185_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	1.805E-12	1.000	394	16	298	443	5	258	266	288	0.639	0.955
LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B	2y7j-assembly1.cif.gz_B Structure of human phosphorylase kinase, gamma 2	1.048E-12	1.000	394	16	295	443	15	278	281	295	0.632	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	2oiq-assembly2.cif.gz_B	2oiq-assembly2.cif.gz_B Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.	4.019E-14	1.000	393	16	300	443	10	257	265	294	0.643	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C	4x3f-assembly3.cif.gz_C Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	1.619E-12	1.000	393	5	299	443	1	264	274	306	0.666	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	2qg5-assembly1.cif.gz_A	2qg5-assembly1.cif.gz_A Cryptosporidium parvum calcium dependent protein kinase cgd7_1840	1.841E-13	1.000	392	16	299	443	26	283	285	293	0.641	0.905
LOKIASV2_0185_ESMFold_hypothetical_protein	5m08-assembly1.cif.gz_A	5m08-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	1.906E-12	1.000	391	2	295	443	1	246	247	298	0.664	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A	4c59-assembly1.cif.gz_A Structure of GAK kinase in complex with nanobody (NbGAK_4)	8.435E-13	1.000	389	7	301	443	4	259	266	308	0.666	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	5fm3-assembly1.cif.gz_A	5fm3-assembly1.cif.gz_A Crystal structure of hyper-phosphorylated RET kinase domain with (proximal) juxtamembrane segment	2.694E-13	1.000	389	3	296	443	6	279	280	312	0.664	0.979
LOKIASV2_0185_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	4.393E-13	1.000	389	16	298	443	11	275	299	297	0.639	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A	4o38-assembly1.cif.gz_A Crystal structure of the human cyclin G associated kinase (GAK)	8.906E-13	1.000	388	6	301	443	5	259	267	310	0.668	0.955
LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly6.cif.gz_D-3	4j97-assembly6.cif.gz_D-3 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	7.166E-13	1.000	388	3	298	443	4	285	285	313	0.668	0.989
LOKIASV2_0185_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B	4o38-assembly1.cif.gz_B Crystal structure of the human cyclin G associated kinase (GAK)	9.929E-13	1.000	387	6	301	443	4	265	276	308	0.668	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	7ozy-assembly1.cif.gz_AAA	7ozy-assembly1.cif.gz_AAA FGFR2 kinase domain (residues 461-763) in complex with 38.	7.166E-13	1.000	387	1	295	443	1	280	281	311	0.666	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	4ypd-assembly1.cif.gz_A	4ypd-assembly1.cif.gz_A Crystal Structure of DAPK1 catalytic domain in complex with the hinge binding fragment 4-methylpyridazine	3.109E-12	1.000	387	16	295	443	12	273	281	294	0.632	0.932
LOKIASV2_0185_ESMFold_hypothetical_protein	7xzr-assembly1.cif.gz_A	7xzr-assembly1.cif.gz_A Crystal structure of TNIK-AMPPNP-thiopeptide TP15 complex	4.898E-13	1.000	386	16	301	443	14	281	299	299	0.646	0.896
LOKIASV2_0185_ESMFold_hypothetical_protein	3el8-assembly2.cif.gz_B	3el8-assembly2.cif.gz_B Crystal structure of c-Src in complex with pyrazolopyrimidine 5	5.172E-13	1.000	385	16	300	443	12	251	259	292	0.643	0.927
LOKIASV2_0185_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A	4b4l-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT	1.107E-12	1.000	385	16	298	443	9	273	299	299	0.639	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B	4c57-assembly2.cif.gz_B Structure of GAK kinase in complex with a nanobody	1.841E-13	1.000	385	6	301	443	3	300	308	327	0.668	0.968
LOKIASV2_0185_ESMFold_hypothetical_protein	7uiq-assembly2.cif.gz_B	7uiq-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1	4.803E-12	1.000	383	16	298	443	6	261	261	294	0.639	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	6fha-assembly1.cif.gz_A	6fha-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289A and S308A mutations	2.125E-12	1.000	383	16	298	443	10	274	299	297	0.639	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A	7oai-assembly1.cif.gz_A Crystal structure of pseudokinase CASK in complex with PFE-PKIS12	3.864E-12	1.000	383	16	300	443	8	276	299	296	0.643	0.900
LOKIASV2_0185_ESMFold_hypothetical_protein	5tur-assembly1.cif.gz_A	5tur-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	1.234E-12	1.000	382	16	296	443	5	269	270	302	0.634	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	3f5g-assembly1.cif.gz_A	3f5g-assembly1.cif.gz_A Crystal structure of death associated protein kinase in complex with ADP and Mg2+	4.549E-12	1.000	382	16	295	443	12	272	279	296	0.632	0.935
LOKIASV2_0185_ESMFold_hypothetical_protein	4i5p-assembly1.cif.gz_A	4i5p-assembly1.cif.gz_A Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain	1.303E-12	1.000	381	8	287	443	1	258	284	288	0.632	0.908
LOKIASV2_0185_ESMFold_hypothetical_protein	7aaz-assembly1.cif.gz_A	7aaz-assembly1.cif.gz_A Crystal structure of MerTK in complex with a type 1.5 aminopyridine inhibitor	9.404E-13	1.000	381	16	296	443	14	286	290	295	0.634	0.941
LOKIASV2_0185_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	3.535E-13	1.000	380	16	299	443	5	256	277	296	0.641	0.910
LOKIASV2_0185_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A	4fg7-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-293 in complex with ATP	5.071E-12	1.000	379	16	296	443	12	249	250	293	0.634	0.952
LOKIASV2_0185_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	1.805E-12	1.000	379	16	298	443	3	287	290	317	0.639	0.983
LOKIASV2_0185_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2	3f3z-assembly1.cif.gz_A-2 Crystal structure of Cryptosporidium parvum calcium dependent protein kinase cgd7_1840 in presence of indirubin E804	1.805E-12	1.000	378	16	308	443	6	267	272	302	0.661	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_D	2y7j-assembly1.cif.gz_D Structure of human phosphorylase kinase, gamma 2	2.244E-12	1.000	378	16	298	443	15	281	281	301	0.639	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	3d5w-assembly1.cif.gz_A	3d5w-assembly1.cif.gz_A Crystal structure of a phosphorylated Polo-like kinase 1 (Plk1) catalytic domain in complex with ADP.	2.641E-12	1.000	376	2	280	443	1	254	285	288	0.630	0.891
LOKIASV2_0185_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	7.566E-13	1.000	376	16	297	443	38	324	331	324	0.637	0.867
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_A	5u6c-assembly1.cif.gz_A Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor	1.048E-12	1.000	375	16	297	443	16	268	272	296	0.637	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H	2a27-assembly4.cif.gz_H Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 8 monomers in the asymmetric unit	1.169E-12	1.000	375	16	298	443	12	276	304	298	0.639	0.872
LOKIASV2_0185_ESMFold_hypothetical_protein	6in4-assembly1.cif.gz_A	6in4-assembly1.cif.gz_A Crystal structure of apo DAPK1 in the presence of 18-crown-6	1.424E-11	1.000	374	16	295	443	12	262	265	291	0.632	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	7avy-assembly1.cif.gz_A	7avy-assembly1.cif.gz_A MerTK kinase domain in complex with quinazoline-based inhbitor	4.080E-12	1.000	374	10	297	443	7	267	270	298	0.650	0.967
LOKIASV2_0185_ESMFold_hypothetical_protein	4k18-assembly1.cif.gz_A	4k18-assembly1.cif.gz_A Structure of PIM-1 kinase bound to 5-(4-cyanobenzyl)-N-(4-fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide	2.244E-12	1.000	374	16	295	443	7	273	277	306	0.632	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A	6qmo-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289E and S308A mutations	2.369E-12	1.000	374	16	297	443	10	273	299	299	0.637	0.883
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6b-assembly4.cif.gz_D	5u6b-assembly4.cif.gz_D Structure of the Axl kinase domain in complex with a macrocyclic inhibitor	2.945E-12	1.000	373	16	298	443	25	290	291	293	0.639	0.914
LOKIASV2_0185_ESMFold_hypothetical_protein	4b6l-assembly1.cif.gz_A	4b6l-assembly1.cif.gz_A Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design	5.354E-12	1.000	372	9	297	443	2	264	281	296	0.652	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B	5xka-assembly1.cif.gz_B Crystal structure of M.tuberculosis PknI kinase domain	2.013E-12	1.000	370	3	297	443	1	250	251	304	0.666	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	6e6e-assembly6.cif.gz_F	6e6e-assembly6.cif.gz_F DGY-06-116, a novel and selective covalent inhibitor of SRC kinase	1.169E-12	1.000	370	16	300	443	10	258	266	293	0.643	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	5.461E-13	1.000	370	16	297	443	10	267	270	294	0.637	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	8.733E-12	1.000	370	16	300	443	7	275	322	295	0.643	0.835
LOKIASV2_0185_ESMFold_hypothetical_protein	4mxz-assembly2.cif.gz_B	4mxz-assembly2.cif.gz_B Src M314L T338M double mutant bound to kinase inhibitor bosutinib	7.566E-13	1.000	369	16	300	443	10	256	264	295	0.643	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	2.125E-12	1.000	369	16	298	443	4	283	292	319	0.639	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A	5y80-assembly1.cif.gz_A Complex structure of cyclin G-associated kinase with gefitinib	5.766E-13	1.000	369	6	309	443	6	304	306	341	0.686	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	1.107E-12	1.000	369	16	298	443	12	306	319	327	0.639	0.925
LOKIASV2_0185_ESMFold_hypothetical_protein	3d15-assembly1.cif.gz_A	3d15-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with 1-(3-chloro-phenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)- ethyl]-thiazol-2-yl}-urea [SNS-314]	4.549E-12	1.000	368	8	298	443	1	254	256	297	0.657	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	1.376E-12	1.000	368	8	303	443	1	279	291	305	0.668	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	2owb-assembly1.cif.gz_A	2owb-assembly1.cif.gz_A Structure of the Catalytic Domain of Human Polo-like Kinase 1	5.354E-12	1.000	368	1	286	443	1	262	294	295	0.646	0.891
LOKIASV2_0185_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	5.461E-13	1.000	368	16	297	443	33	324	326	326	0.637	0.896
LOKIASV2_0185_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2	4c58-assembly1.cif.gz_A-2 Structure of GAK kinase in complex with nanobody (NbGAK_4)	6.303E-12	1.000	367	7	301	443	4	260	267	311	0.666	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	5x1s-assembly1.cif.gz_A	5x1s-assembly1.cif.gz_A PpkA-294 with Amppcp	1.085E-11	1.000	367	1	291	443	1	280	281	311	0.657	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	2.200E-11	1.000	367	16	296	443	11	259	283	290	0.634	0.880
LOKIASV2_0185_ESMFold_hypothetical_protein	2x0g-assembly1.cif.gz_A	2x0g-assembly1.cif.gz_A X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX	6.655E-12	1.000	367	16	298	443	11	276	318	297	0.639	0.836
LOKIASV2_0185_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2	6o6q-assembly1.cif.gz_B-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	1.169E-12	1.000	367	16	297	443	39	320	325	323	0.637	0.868
LOKIASV2_0185_ESMFold_hypothetical_protein	7n3u-assembly1.cif.gz_A	7n3u-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with ZN-c3	2.084E-11	1.000	365	16	289	443	7	256	261	280	0.619	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A	5lvl-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site	7.419E-12	1.000	365	16	281	443	9	252	286	272	0.600	0.853
LOKIASV2_0185_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A	5li1-assembly1.cif.gz_A Structure of a Par3-inhibitory peptide bound to PKCiota core kinase domain	4.803E-12	1.000	363	9	297	443	3	278	334	307	0.652	0.826
LOKIASV2_0185_ESMFold_hypothetical_protein	3ion-assembly1.cif.gz_A	3ion-assembly1.cif.gz_A PDK1 in complex with Compound 8h	3.864E-12	1.000	362	16	310	443	8	259	274	302	0.666	0.920
LOKIASV2_0185_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B	4y8d-assembly2.cif.gz_B Crystal structure of Cyclin-G associated kinase (GAK) complexed with selective 12i inhibitor	1.028E-11	1.000	361	7	301	443	4	255	262	308	0.666	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	3vf9-assembly1.cif.gz_A	3vf9-assembly1.cif.gz_A Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Thienopyrazolylindole Inhibitor 027	2.590E-11	1.000	361	16	297	443	7	262	265	290	0.637	0.966
LOKIASV2_0185_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	7.419E-12	1.000	360	16	310	443	11	264	277	302	0.666	0.917
LOKIASV2_0185_ESMFold_hypothetical_protein	2pzp-assembly1.cif.gz_B	2pzp-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	3.109E-12	1.000	360	30	296	443	22	278	282	283	0.603	0.911
LOKIASV2_0185_ESMFold_hypothetical_protein	2pvy-assembly1.cif.gz_C	2pvy-assembly1.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.	2.502E-12	1.000	360	20	298	443	6	285	285	310	0.630	0.982
LOKIASV2_0185_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C	3eid-assembly2.cif.gz_C CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	3.283E-12	1.000	360	16	298	443	4	282	290	317	0.639	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	7avx-assembly2.cif.gz_B	7avx-assembly2.cif.gz_B MerTK kinase domain in complex with NPS-1034	7.027E-12	1.000	359	16	296	443	11	260	263	292	0.634	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	3bht-assembly2.cif.gz_C	3bht-assembly2.cif.gz_C Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 3	2.200E-11	1.000	359	16	298	443	5	263	271	293	0.639	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	4j7b-assembly2.cif.gz_D	4j7b-assembly2.cif.gz_D Crystal structure of polo-like kinase 1	2.590E-11	1.000	359	1	298	443	4	263	281	305	0.673	0.925
LOKIASV2_0185_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A	4csv-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl bound to Gleevec	5.354E-12	1.000	358	16	292	443	9	240	244	284	0.625	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	2wqn-assembly1.cif.gz_A	2wqn-assembly1.cif.gz_A Structure of ADP-bound human Nek7	6.526E-11	1.000	358	3	297	443	1	257	259	306	0.666	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	6.655E-12	1.000	358	16	298	443	4	288	289	317	0.639	0.986
LOKIASV2_0185_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	1.710E-12	1.000	358	16	297	443	6	291	294	321	0.637	0.973
LOKIASV2_0185_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A	3mfu-assembly1.cif.gz_A CASK-4M CaM Kinase Domain, AMPPNP-Mn2+	4.803E-12	1.000	358	16	300	443	8	276	302	299	0.643	0.891
LOKIASV2_0185_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	4.898E-13	1.000	357	13	309	443	20	292	475	313	0.670	0.575
LOKIASV2_0185_ESMFold_hypothetical_protein	3brb-assembly2.cif.gz_B	3brb-assembly2.cif.gz_B Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with ADP	3.466E-12	1.000	356	16	297	443	13	268	271	301	0.637	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	2i40-assembly1.cif.gz_A	2i40-assembly1.cif.gz_A Cdk2/Cyclin A complexed with a thiophene carboxamide inhibitor	9.736E-12	1.000	356	16	298	443	4	282	291	317	0.639	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	2.789E-12	1.000	356	16	297	443	6	293	297	321	0.637	0.970
LOKIASV2_0185_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	4.803E-12	1.000	356	16	300	443	11	277	300	303	0.643	0.890
LOKIASV2_0185_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A	2wtw-assembly1.cif.gz_A Aurora-A Inhibitor Structure (2nd crystal form)	1.210E-11	1.000	355	16	298	443	6	253	256	289	0.639	0.969
LOKIASV2_0185_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B	5de2-assembly2.cif.gz_B Structural mechanism of Nek7 activation by Nek9-induced dimerisation	2.888E-11	1.000	355	16	298	443	15	261	262	292	0.639	0.943
LOKIASV2_0185_ESMFold_hypothetical_protein	7aw3-assembly1.cif.gz_A	7aw3-assembly1.cif.gz_A MerTK kinase domain with type 1 inhibitor from a DNA-encoded library	2.945E-12	1.000	355	10	296	443	15	266	269	307	0.648	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	2x6d-assembly1.cif.gz_A	2x6d-assembly1.cif.gz_A Aurora-A bound to an inhibitor	1.974E-11	1.000	354	8	298	443	1	253	255	298	0.657	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	5yvc-assembly1.cif.gz_A	5yvc-assembly1.cif.gz_A Structure of CaMKK2 in complex with CKI-012	1.028E-11	1.000	354	10	288	443	1	252	259	293	0.630	0.973
LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	5.071E-12	1.000	354	16	300	443	2	275	276	324	0.643	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	7.419E-12	1.000	354	16	280	443	9	242	277	273	0.598	0.845
LOKIASV2_0185_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	2.789E-12	1.000	354	16	296	443	52	337	344	323	0.634	0.831
LOKIASV2_0185_ESMFold_hypothetical_protein	7m5z-assembly1.cif.gz_A	7m5z-assembly1.cif.gz_A Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692	8.733E-12	1.000	353	16	297	443	11	261	263	296	0.637	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly1.cif.gz_A	6s73-assembly1.cif.gz_A Crystal structure of Nek7 SRS mutant bound to compound 51	2.084E-11	1.000	353	16	297	443	14	267	269	291	0.637	0.944
LOKIASV2_0185_ESMFold_hypothetical_protein	7olv-assembly1.cif.gz_A	7olv-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group	1.085E-11	1.000	353	16	296	443	21	270	273	295	0.634	0.916
LOKIASV2_0185_ESMFold_hypothetical_protein	2g2f-assembly1.cif.gz_A	2g2f-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	2.244E-12	1.000	353	16	297	443	11	268	275	294	0.637	0.938
LOKIASV2_0185_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	2.641E-12	1.000	353	16	310	443	10	267	281	303	0.666	0.918
LOKIASV2_0185_ESMFold_hypothetical_protein	3bqr-assembly1.cif.gz_A-2	3bqr-assembly1.cif.gz_A-2 Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with an imidazo-pyridazine ligand	8.271E-12	1.000	352	16	296	443	7	266	275	296	0.634	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	7avx-assembly1.cif.gz_A	7avx-assembly1.cif.gz_A MerTK kinase domain in complex with NPS-1034	7.419E-12	1.000	352	16	296	443	11	273	276	294	0.634	0.953
LOKIASV2_0185_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D	3orz-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment activator 2A2	7.834E-12	1.000	352	16	281	443	10	245	279	274	0.600	0.846
LOKIASV2_0185_ESMFold_hypothetical_protein	4eol-assembly1.cif.gz_A	4eol-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	3.660E-12	1.000	352	16	298	443	5	286	295	317	0.639	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	6l22-assembly1.cif.gz_A	6l22-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y with hematein	5.172E-13	1.000	352	16	307	443	38	333	334	337	0.659	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	6l8l-assembly4.cif.gz_D	6l8l-assembly4.cif.gz_D C-Src in complex with ibrutinib	8.733E-12	1.000	351	16	300	443	6	248	256	294	0.643	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_A	3is5-assembly1.cif.gz_A Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	1.124E-10	1.000	351	16	292	443	12	259	260	287	0.625	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	7ab2-assembly1.cif.gz_A	7ab2-assembly1.cif.gz_A Crystal structure of MerTK kinase domain in complex with UNC2025	9.221E-12	1.000	351	10	296	443	15	267	270	304	0.648	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A	3d5u-assembly1.cif.gz_A Crystal structure of a wildtype Polo-like kinase 1 (Plk1) catalytic domain.	1.770E-11	1.000	351	1	281	443	1	258	288	289	0.634	0.896
LOKIASV2_0185_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_A-2	6o6q-assembly1.cif.gz_A-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	2.945E-12	1.000	351	16	298	443	40	323	326	325	0.639	0.871
LOKIASV2_0185_ESMFold_hypothetical_protein	5vdk-assembly1.cif.gz_A	5vdk-assembly1.cif.gz_A Crystal structure of human WEE2 kinase domain in complex with MK1775	2.590E-11	1.000	350	16	291	443	9	254	260	282	0.623	0.946
LOKIASV2_0185_ESMFold_hypothetical_protein	1oi9-assembly1.cif.gz_A	1oi9-assembly1.cif.gz_A Structure of human Thr160-phospho CDK2/cyclin A complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor	1.770E-11	1.000	350	16	298	443	5	288	296	317	0.639	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	1.453E-12	1.000	350	16	309	443	26	324	326	338	0.664	0.917
LOKIASV2_0185_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	8.435E-13	1.000	350	16	309	443	31	329	331	336	0.664	0.903
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_F	3is5-assembly1.cif.gz_F Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	4.224E-11	1.000	349	16	298	443	13	265	266	293	0.639	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A	6fvg-assembly1.cif.gz_A The Structure of CK2alpha with CCh507 bound	3.864E-12	1.000	349	16	298	443	37	324	327	326	0.639	0.881
LOKIASV2_0185_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A	6l23-assembly1.cif.gz_A Crystal structure of CK2a1 V116I with hematein	2.945E-12	1.000	349	16	307	443	38	333	334	334	0.659	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	2.084E-11	1.000	349	13	296	443	19	275	464	294	0.641	0.554
LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	2.323E-11	1.000	348	16	299	443	3	276	277	320	0.641	0.989
LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	6.303E-12	1.000	348	16	299	443	3	277	278	320	0.641	0.989
LOKIASV2_0185_ESMFold_hypothetical_protein	8b54-assembly2.cif.gz_C	8b54-assembly2.cif.gz_C CDK2/cyclin A2 in complex with pyrazolo[4,3-d]pyrimidine inhibitor LGR6768	1.424E-11	1.000	348	16	298	443	4	286	292	317	0.639	0.969
LOKIASV2_0185_ESMFold_hypothetical_protein	3g2f-assembly2.cif.gz_B	3g2f-assembly2.cif.gz_B Crystal structure of the kinase domain of bone morphogenetic protein receptor type II (BMPR2) at 2.35 A resolution	2.244E-12	1.000	348	16	296	443	6	293	300	330	0.634	0.960
LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C	6s73-assembly3.cif.gz_C Crystal structure of Nek7 SRS mutant bound to compound 51	1.187E-10	1.000	347	4	297	443	1	257	259	301	0.664	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	1.736E-10	1.000	346	16	295	443	12	234	236	282	0.632	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A	7kx8-assembly1.cif.gz_A Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	3.399E-11	1.000	346	13	298	443	7	251	263	293	0.646	0.932
LOKIASV2_0185_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A	2r7b-assembly1.cif.gz_A Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dibenzonaphthyridine inhibitor	1.424E-11	1.000	346	16	281	443	8	240	274	273	0.600	0.850
LOKIASV2_0185_ESMFold_hypothetical_protein	4j7b-assembly1.cif.gz_A	4j7b-assembly1.cif.gz_A Crystal structure of polo-like kinase 1	5.853E-11	1.000	346	1	298	443	6	266	284	305	0.673	0.919
LOKIASV2_0185_ESMFold_hypothetical_protein	3db6-assembly1.cif.gz_A	3db6-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 902	3.049E-11	1.000	346	2	281	443	1	257	287	287	0.632	0.895
LOKIASV2_0185_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A	4eok-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor NU6102	4.080E-12	1.000	346	16	298	443	5	285	294	317	0.639	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2t-assembly4.cif.gz_D	4d2t-assembly4.cif.gz_D Structure of MELK in complex with inhibitors	6.303E-12	1.000	346	16	301	443	9	259	319	293	0.646	0.787
LOKIASV2_0185_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A	6lnm-assembly1.cif.gz_A Crystal structure of CASK-CaMK in complex with Mint1-CID	1.028E-11	1.000	346	16	300	443	7	275	325	297	0.643	0.828
LOKIASV2_0185_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B	8bgc-assembly2.cif.gz_B Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS-9-003)	3.466E-12	1.000	346	16	295	443	37	318	327	325	0.632	0.862
LOKIASV2_0185_ESMFold_hypothetical_protein	7a1z-assembly1.cif.gz_A	7a1z-assembly1.cif.gz_A Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the ATP-competitive inhibitor 6-bromo-5-chloro-1H-triazolo[4,5-b]pyridine	7.027E-12	1.000	346	16	295	443	34	318	328	322	0.632	0.869
LOKIASV2_0185_ESMFold_hypothetical_protein	4o0s-assembly1.cif.gz_A	4o0s-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	2.735E-11	1.000	345	8	299	443	1	260	265	298	0.659	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	3qd2-assembly1.cif.gz_B	3qd2-assembly1.cif.gz_B Crystal structure of mouse PERK kinase domain	1.278E-11	1.000	345	16	289	443	8	265	272	295	0.619	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	3.660E-12	1.000	345	16	295	443	33	315	321	322	0.632	0.882
LOKIASV2_0185_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A	6l24-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y/V116I with hematein	1.303E-12	1.000	345	16	307	443	38	333	334	334	0.659	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	4mh7-assembly1.cif.gz_A	4mh7-assembly1.cif.gz_A Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1896	2.453E-11	1.000	344	10	297	443	6	247	248	301	0.650	0.976
LOKIASV2_0185_ESMFold_hypothetical_protein	4hjo-assembly1.cif.gz_A	4hjo-assembly1.cif.gz_A Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib	1.028E-11	1.000	344	10	308	443	5	276	278	306	0.675	0.978
LOKIASV2_0185_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	2.590E-11	1.000	344	16	281	443	11	248	282	273	0.600	0.844
LOKIASV2_0185_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_C	2wtk-assembly2.cif.gz_C Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	1.278E-11	1.000	344	16	289	443	3	256	285	284	0.619	0.891
LOKIASV2_0185_ESMFold_hypothetical_protein	7aw2-assembly1.cif.gz_A	7aw2-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded library	1.974E-11	1.000	343	16	296	443	20	267	270	292	0.634	0.919
LOKIASV2_0185_ESMFold_hypothetical_protein	3g2f-assembly1.cif.gz_A	3g2f-assembly1.cif.gz_A Crystal structure of the kinase domain of bone morphogenetic protein receptor type II (BMPR2) at 2.35 A resolution	1.619E-12	1.000	343	16	296	443	7	298	302	331	0.634	0.967
LOKIASV2_0185_ESMFold_hypothetical_protein	4ra5-assembly1.cif.gz_B	4ra5-assembly1.cif.gz_B Human Protein Kinase C THETA IN COMPLEX WITH LIGAND COMPOUND 11a (6-[(1,3-Dimethyl-azetidin-3-yl)-methyl-amino]-4(R)-methyl-7-phenyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)	1.974E-11	1.000	343	10	282	443	1	249	312	278	0.616	0.798
LOKIASV2_0185_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	7.419E-12	1.000	343	16	295	443	33	315	323	322	0.632	0.876
LOKIASV2_0185_ESMFold_hypothetical_protein	3orx-assembly5.cif.gz_E	3orx-assembly5.cif.gz_E PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	5.654E-12	1.000	342	16	310	443	7	259	274	303	0.666	0.923
LOKIASV2_0185_ESMFold_hypothetical_protein	4a4o-assembly1.cif.gz_A-2	4a4o-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO- PYRIMIDIN-4-YL)-1,5,6,7-TETRAHYDRO-PYRROLOPYRIDIN-4-ONE INHIBITOR	2.323E-11	1.000	342	14	298	443	13	270	290	291	0.643	0.890
LOKIASV2_0185_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	4.549E-12	1.000	342	16	298	443	7	291	300	320	0.639	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A	5h8g-assembly1.cif.gz_A Crystal structure of CK2 with compound 7b	7.834E-12	1.000	342	16	296	443	37	320	324	324	0.634	0.877
LOKIASV2_0185_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D	4dgl-assembly1.cif.gz_D Crystal Structure of the CK2 Tetrameric Holoenzyme	5.071E-12	1.000	342	16	295	443	37	321	328	323	0.632	0.869
LOKIASV2_0185_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A	5n3b-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-(pyridin-3-yl)ethanamine	3.049E-11	1.000	342	6	290	443	30	290	346	296	0.643	0.754
LOKIASV2_0185_ESMFold_hypothetical_protein	5os5-assembly1.cif.gz_A	5os5-assembly1.cif.gz_A Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment	5.544E-11	1.000	341	8	298	443	2	262	268	297	0.657	0.974
LOKIASV2_0185_ESMFold_hypothetical_protein	6bqq-assembly1.cif.gz_A	6bqq-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with BI2526	1.770E-11	1.000	341	10	288	443	2	264	271	299	0.630	0.970
LOKIASV2_0185_ESMFold_hypothetical_protein	3a7g-assembly2.cif.gz_B	3a7g-assembly2.cif.gz_B Human MST3 kinase	2.125E-12	1.000	341	3	299	443	1	270	291	315	0.670	0.928
LOKIASV2_0185_ESMFold_hypothetical_protein	6guc-assembly1.cif.gz_A	6guc-assembly1.cif.gz_A CDK2/CyclinA in complex with SU9516	1.677E-11	1.000	341	16	298	443	5	284	292	320	0.639	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	2.789E-12	1.000	341	16	300	443	34	324	328	328	0.643	0.887
LOKIASV2_0185_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A	5li9-assembly1.cif.gz_A Structure of a nucleotide-bound form of PKCiota core kinase domain	1.974E-11	1.000	341	8	297	443	1	275	331	308	0.655	0.831
LOKIASV2_0185_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B	2buj-assembly2.cif.gz_B Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	1.677E-11	1.000	340	4	294	443	4	282	286	317	0.657	0.976
LOKIASV2_0185_ESMFold_hypothetical_protein	5uuu-assembly1.cif.gz_A	5uuu-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	9.221E-12	1.000	340	10	297	443	75	353	414	307	0.650	0.674
LOKIASV2_0185_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A	4yzb-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1521	3.789E-11	1.000	340	13	292	443	19	276	466	291	0.632	0.554
LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D	6s73-assembly4.cif.gz_D Crystal structure of Nek7 SRS mutant bound to compound 51	1.323E-10	1.000	339	16	297	443	12	257	259	292	0.637	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A	5z33-assembly1.cif.gz_A Crystal structure of Mitogen-activated Protein Kinase Mps1 in Magnaporthe oryzae	2.013E-12	1.000	339	5	304	443	1	319	375	347	0.677	0.851
LOKIASV2_0185_ESMFold_hypothetical_protein	3tcp-assembly2.cif.gz_B	3tcp-assembly2.cif.gz_B Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569	4.224E-11	1.000	338	5	297	443	1	249	250	307	0.661	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	2.200E-11	1.000	338	16	280	443	7	243	278	273	0.598	0.853
LOKIASV2_0185_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A	6gih-assembly1.cif.gz_A Crystal Structure of CK2alpha with CAM187 bound	8.733E-12	1.000	338	16	298	443	37	321	324	326	0.639	0.880
LOKIASV2_0185_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_A	3a8x-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	4.710E-11	1.000	338	8	297	443	2	281	336	310	0.655	0.833
LOKIASV2_0185_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A	2biy-assembly1.cif.gz_A Structure of PDK1-S241A mutant kinase domain	1.210E-11	1.000	337	16	310	443	11	273	287	302	0.666	0.916
LOKIASV2_0185_ESMFold_hypothetical_protein	5ts8-assembly1.cif.gz_A	5ts8-assembly1.cif.gz_A Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE	5.354E-12	1.000	337	16	300	443	33	327	332	332	0.643	0.889
LOKIASV2_0185_ESMFold_hypothetical_protein	1k9a-assembly7.cif.gz_D-2	1k9a-assembly7.cif.gz_D-2 Crystal structure analysis of full-length carboxyl-terminal Src kinase at 2.5 A resolution	5.071E-12	1.000	337	10	299	443	178	431	433	298	0.655	0.587
LOKIASV2_0185_ESMFold_hypothetical_protein	5lvp-assembly2.cif.gz_B	5lvp-assembly2.cif.gz_B Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	4.001E-11	1.000	336	16	281	443	9	243	277	274	0.600	0.848
LOKIASV2_0185_ESMFold_hypothetical_protein	4ct1-assembly1.cif.gz_A	4ct1-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket	1.210E-11	1.000	336	16	310	443	7	269	284	303	0.666	0.926
LOKIASV2_0185_ESMFold_hypothetical_protein	5am7-assembly1.cif.gz_A	5am7-assembly1.cif.gz_A FGFR1 mutant with an inhibitor	8.733E-12	1.000	336	3	296	443	9	289	294	312	0.664	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A	5es1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR	3.399E-11	1.000	336	16	299	443	6	252	304	292	0.641	0.812
LOKIASV2_0185_ESMFold_hypothetical_protein	3zh8-assembly3.cif.gz_C	3zh8-assembly3.cif.gz_C A novel small molecule aPKC inhibitor	6.180E-11	1.000	336	10	298	443	2	269	314	300	0.652	0.854
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_B	5u6c-assembly1.cif.gz_B Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor	1.869E-11	1.000	335	16	296	443	13	254	257	295	0.634	0.942
LOKIASV2_0185_ESMFold_hypothetical_protein	3h0z-assembly1.cif.gz_A	3h0z-assembly1.cif.gz_A Aurora A in complex with a bisanilinopyrimidine	4.973E-11	1.000	334	16	299	443	6	246	248	289	0.641	0.972
LOKIASV2_0185_ESMFold_hypothetical_protein	5os2-assembly1.cif.gz_A	5os2-assembly1.cif.gz_A Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment	8.111E-11	1.000	334	16	298	443	7	256	261	289	0.639	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly1.cif.gz_A	6s75-assembly1.cif.gz_A Crystal structure of Nek7 bound to compound 51	1.397E-10	1.000	334	16	297	443	16	265	267	294	0.637	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	6unp-assembly2.cif.gz_B	6unp-assembly2.cif.gz_B Crystal structure of the kinase domain of BMPR2-D485G	7.834E-12	1.000	334	16	297	443	7	297	300	329	0.637	0.970
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_D	4d2w-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	1.210E-11	1.000	334	16	301	443	11	262	326	292	0.646	0.773
LOKIASV2_0185_ESMFold_hypothetical_protein	8cav-assembly1.cif.gz_A	8cav-assembly1.cif.gz_A Discovery of the lanthipeptide Curvocidin and structural insights into its trifunctional synthetase CuvL	3.864E-12	1.000	334	1	297	443	196	464	860	315	0.670	0.313
LOKIASV2_0185_ESMFold_hypothetical_protein	2h34-assembly2.cif.gz_B	2h34-assembly2.cif.gz_B Apoenzyme crystal structure of the tuberculosis serine/threonine kinase, PknE	2.682E-10	1.000	333	16	292	443	3	239	243	285	0.625	0.975
LOKIASV2_0185_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A	2c6e-assembly1.cif.gz_A Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	4.710E-11	1.000	333	16	298	443	7	248	251	290	0.639	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	5zan-assembly1.cif.gz_A	5zan-assembly1.cif.gz_A Crystal Structure of Aurora-A in complex with a new Quinazoline inhibitor	4.710E-11	1.000	333	16	298	443	7	255	258	291	0.639	0.965
LOKIASV2_0185_ESMFold_hypothetical_protein	5drd-assembly1.cif.gz_A	5drd-assembly1.cif.gz_A Aurora A Kinase in Complex with ATP in Space Group P6122	3.789E-11	1.000	333	16	299	443	7	255	259	291	0.641	0.961
LOKIASV2_0185_ESMFold_hypothetical_protein	8ej4-assembly1.cif.gz_K	8ej4-assembly1.cif.gz_K Cryo-EM structure of the active NLRP3 inflammasome disk	1.253E-10	1.000	333	16	295	443	15	260	261	287	0.632	0.943
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6b-assembly3.cif.gz_C	5u6b-assembly3.cif.gz_C Structure of the Axl kinase domain in complex with a macrocyclic inhibitor	3.049E-11	1.000	333	16	297	443	16	266	270	293	0.637	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	3aox-assembly1.cif.gz_A	3aox-assembly1.cif.gz_A X-ray crystal structure of human anaplastic lymphoma kinase in complex with CH5424802	7.027E-12	1.000	333	7	303	443	8	291	298	323	0.670	0.953
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	1.048E-12	1.000	333	16	294	443	10	286	317	316	0.630	0.874
LOKIASV2_0185_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A	2vo0-assembly1.cif.gz_A Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine	1.424E-11	1.000	333	10	298	443	31	292	343	300	0.652	0.764
LOKIASV2_0185_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A	8ahi-assembly1.cif.gz_A PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discovery	4.710E-11	1.000	332	5	297	443	14	274	292	304	0.661	0.894
LOKIASV2_0185_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B	4btj-assembly2.cif.gz_B TTBK1 in complex with ATP	1.397E-10	1.000	332	4	300	443	4	281	293	308	0.670	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	5f9e-assembly2.cif.gz_B	5f9e-assembly2.cif.gz_B Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	8.111E-11	1.000	332	10	297	443	1	271	294	303	0.650	0.922
LOKIASV2_0185_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B	8pqc-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 9	3.399E-11	1.000	332	3	298	443	12	295	295	312	0.668	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	5.853E-11	1.000	332	9	297	443	1	266	316	298	0.652	0.842
LOKIASV2_0185_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	6.655E-12	1.000	332	16	297	443	33	322	324	333	0.637	0.895
LOKIASV2_0185_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A	5ouu-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 22	1.278E-11	1.000	332	16	298	443	38	322	324	325	0.639	0.880
LOKIASV2_0185_ESMFold_hypothetical_protein	1na7-assembly1.cif.gz_A	1na7-assembly1.cif.gz_A Crystal structure of the catalytic subunit of human protein kinase CK2	7.834E-12	1.000	332	16	298	443	36	323	326	326	0.639	0.883
LOKIASV2_0185_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D	3h10-assembly3.cif.gz_D Aurora A inhibitor complex	4.710E-11	1.000	330	8	298	443	1	253	255	296	0.657	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B	3is5-assembly1.cif.gz_B Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	3.923E-10	1.000	330	16	292	443	11	258	260	289	0.625	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_A	5a6n-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	1.424E-11	1.000	330	13	297	443	4	270	271	306	0.643	0.985
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_A	5ng2-assembly1.cif.gz_A Structure of RIP2K(D146N) with bound Staurosporine	6.180E-11	1.000	330	9	296	443	14	271	274	304	0.650	0.942
LOKIASV2_0185_ESMFold_hypothetical_protein	8stg-assembly1.cif.gz_A	8stg-assembly1.cif.gz_A Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations	2.590E-11	1.000	330	16	298	443	21	277	277	298	0.639	0.928
LOKIASV2_0185_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A	4cqg-assembly1.cif.gz_A The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor	2.323E-11	1.000	330	16	301	443	10	249	313	293	0.646	0.767
LOKIASV2_0185_ESMFold_hypothetical_protein	6kyq-assembly2.cif.gz_B	6kyq-assembly2.cif.gz_B Crystal structure of DCLK1 Autoinhibited Kinase Domain	1.974E-11	1.000	330	16	300	443	11	268	317	297	0.643	0.814
LOKIASV2_0185_ESMFold_hypothetical_protein	6t6f-assembly1.cif.gz_A	6t6f-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 8 (CS275)	1.424E-11	1.000	329	16	311	443	12	284	288	318	0.668	0.948
LOKIASV2_0185_ESMFold_hypothetical_protein	4twc-assembly2.cif.gz_B	4twc-assembly2.cif.gz_B 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	8.111E-11	1.000	329	8	297	443	1	276	292	303	0.655	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	6bku-assembly1.cif.gz_A	6bku-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B bound to GSK650394	5.853E-11	1.000	328	10	288	443	2	260	267	297	0.630	0.970
LOKIASV2_0185_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	1.935E-10	1.000	327	16	288	443	3	243	249	284	0.616	0.968
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E	3is5-assembly1.cif.gz_E Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	4.876E-10	1.000	327	16	290	443	15	250	252	276	0.621	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A	4jbq-assembly1.cif.gz_A Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	1.475E-10	1.000	327	8	298	443	1	252	257	297	0.657	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A	1how-assembly1.cif.gz_A THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST	7.027E-12	1.000	327	4	305	443	4	324	346	348	0.682	0.928
LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly3.cif.gz_C	4wbo-assembly3.cif.gz_C Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	9.736E-12	1.000	327	6	294	443	148	423	481	302	0.652	0.574
LOKIASV2_0185_ESMFold_hypothetical_protein	5dpv-assembly1.cif.gz_A	5dpv-assembly1.cif.gz_A Aurora A Kinase in Complex with AA35 and JNJ-7706621 in Space Group P6122	1.008E-10	1.000	326	16	298	443	7	254	257	291	0.639	0.965
LOKIASV2_0185_ESMFold_hypothetical_protein	3g5d-assembly2.cif.gz_B	3g5d-assembly2.cif.gz_B Kinase domain of cSrc in complex with Dasatinib	8.564E-11	1.000	326	16	300	443	10	249	257	292	0.643	0.934
LOKIASV2_0185_ESMFold_hypothetical_protein	6bqp-assembly1.cif.gz_A	6bqp-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with Crenolanib	6.180E-11	1.000	326	10	288	443	1	256	263	293	0.630	0.973
LOKIASV2_0185_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A	3dbe-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 557	2.043E-10	1.000	326	2	292	443	1	266	284	299	0.657	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly4.cif.gz_D	7nzy-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with CGS-15943	7.275E-11	1.000	326	10	302	443	1	278	285	313	0.661	0.975
LOKIASV2_0185_ESMFold_hypothetical_protein	2cjm-assembly2.cif.gz_A	2cjm-assembly2.cif.gz_A Mechanism of CDK inhibition by active site phosphorylation: CDK2 Y15p T160p in complex with cyclin A structure	4.710E-11	1.000	326	16	298	443	4	283	287	317	0.639	0.976
LOKIASV2_0185_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	5.251E-11	1.000	326	16	302	443	23	283	287	301	0.648	0.909
LOKIASV2_0185_ESMFold_hypothetical_protein	6kyr-assembly2.cif.gz_B	6kyr-assembly2.cif.gz_B Crystal structure of DCLK1 mutant (P675L) Autoinhibited Kinase Domain	2.200E-11	1.000	326	16	300	443	11	269	310	298	0.643	0.835
LOKIASV2_0185_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	1.833E-10	1.000	326	9	298	443	1	267	319	298	0.655	0.837
LOKIASV2_0185_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B	3w8l-assembly2.cif.gz_B Crystal structure of human CK2 in complex with inositol hexakisphosphate	1.869E-11	1.000	326	16	295	443	36	320	326	324	0.632	0.874
LOKIASV2_0185_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B	7psu-assembly2.cif.gz_B Structure of protein kinase CK2alpha mutant K198R associated with the Okur-Chung Neurodevelopmental Syndrome	1.278E-11	1.000	326	16	296	443	38	323	332	328	0.634	0.861
LOKIASV2_0185_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E	1apm-assembly1.cif.gz_E 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT	7.275E-11	1.000	326	10	288	443	29	283	341	292	0.630	0.748
LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly2.cif.gz_B	4wbo-assembly2.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	9.736E-12	1.000	326	6	294	443	149	424	495	302	0.652	0.558
LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly3.cif.gz_C	6s75-assembly3.cif.gz_C Crystal structure of Nek7 bound to compound 51	2.990E-10	1.000	325	16	297	443	13	261	263	291	0.637	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A	5lqf-assembly1.cif.gz_A CDK1/CyclinB1/CKS2 in complex with NU6102	2.590E-11	1.000	325	16	298	443	7	287	287	320	0.639	0.979
LOKIASV2_0185_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	1.770E-11	1.000	325	14	301	443	2	286	298	329	0.650	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	1.253E-10	1.000	325	9	297	443	1	266	320	298	0.652	0.831
LOKIASV2_0185_ESMFold_hypothetical_protein	2jed-assembly2.cif.gz_B	2jed-assembly2.cif.gz_B The crystal structure of the kinase domain of the protein kinase C theta in complex with NVP-XAA228 at 2.32A resolution.	7.682E-11	1.000	325	10	297	443	1	271	322	300	0.650	0.842
LOKIASV2_0185_ESMFold_hypothetical_protein	3l9m-assembly2.cif.gz_B	3l9m-assembly2.cif.gz_B Crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 18	4.973E-11	1.000	325	16	298	443	31	287	338	294	0.639	0.760
LOKIASV2_0185_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A	3nie-assembly3.cif.gz_A Crystal Structure of PF11_0147	5.969E-12	1.000	325	10	299	443	11	320	369	346	0.655	0.840
LOKIASV2_0185_ESMFold_hypothetical_protein	5k0k-assembly2.cif.gz_B	5k0k-assembly2.cif.gz_B Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC2434	5.544E-11	1.000	324	16	298	443	11	247	248	295	0.639	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	6yid-assembly2.cif.gz_C	6yid-assembly2.cif.gz_C Crystal structure of ULK2 in complex with SBI-0206965	7.275E-11	1.000	324	7	288	443	2	253	259	296	0.637	0.973
LOKIASV2_0185_ESMFold_hypothetical_protein	7olx-assembly1.cif.gz_A	7olx-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group	3.789E-11	1.000	324	16	296	443	21	272	275	296	0.634	0.916
LOKIASV2_0185_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	1.677E-11	1.000	324	5	296	443	15	275	290	313	0.659	0.900
LOKIASV2_0185_ESMFold_hypothetical_protein	4fob-assembly1.cif.gz_A	4fob-assembly1.cif.gz_A Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 1	1.349E-11	1.000	324	8	296	443	2	281	295	312	0.652	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	4q9z-assembly1.cif.gz_B	4q9z-assembly1.cif.gz_B Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)	1.187E-10	1.000	324	10	297	443	2	272	309	300	0.650	0.877
LOKIASV2_0185_ESMFold_hypothetical_protein	6npz-assembly1.cif.gz_A	6npz-assembly1.cif.gz_A Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	9.547E-11	1.000	324	8	298	443	2	269	322	298	0.657	0.832
LOKIASV2_0185_ESMFold_hypothetical_protein	5uvc-assembly1.cif.gz_A	5uvc-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	2.453E-11	1.000	324	10	297	443	130	408	457	307	0.650	0.611
LOKIASV2_0185_ESMFold_hypothetical_protein	4mha-assembly2.cif.gz_B	4mha-assembly2.cif.gz_B Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1817	1.124E-10	1.000	323	16	298	443	11	245	246	296	0.639	0.955
LOKIASV2_0185_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C	8edh-assembly2.cif.gz_C Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	2.735E-11	1.000	323	16	295	443	11	258	261	290	0.632	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	3ue4-assembly2.cif.gz_B	3ue4-assembly2.cif.gz_B Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the Abl tyrosine kinase domain	1.064E-10	1.000	323	16	297	443	10	265	268	290	0.637	0.955
LOKIASV2_0185_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A	4f1o-assembly1.cif.gz_A Crystal Structure of the L1180T mutant Roco4 Kinase Domain from D. discoideum bound to AppCp	5.544E-11	1.000	323	16	293	443	10	275	276	298	0.628	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	3d5x-assembly1.cif.gz_A	3d5x-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with wortmannin.	1.557E-10	1.000	323	2	298	443	1	264	279	312	0.670	0.946
LOKIASV2_0185_ESMFold_hypothetical_protein	6hmr-assembly2.cif.gz_B	6hmr-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with a photoswitchable 2-Azothiazole-based inhibitor (compound 2)	1.475E-10	1.000	323	10	297	443	4	266	280	299	0.650	0.939
LOKIASV2_0185_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C	7p7f-assembly3.cif.gz_C Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 1	1.064E-10	1.000	323	13	297	443	4	270	285	298	0.643	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	3zh8-assembly2.cif.gz_B	3zh8-assembly2.cif.gz_B A novel small molecule aPKC inhibitor	1.935E-10	1.000	323	10	298	443	2	269	319	300	0.652	0.840
LOKIASV2_0185_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E	4md9-assembly1.cif.gz_E Crystal Structure of symmetric CK2 holoenzyme with mutated alpha subunit (F121E truncated at aa 336)	1.210E-11	1.000	323	16	295	443	38	322	329	326	0.632	0.866
LOKIASV2_0185_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C	6b1u-assembly2.cif.gz_C Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	1.974E-11	1.000	323	8	310	443	1	282	460	315	0.684	0.613
LOKIASV2_0185_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A	2xik-assembly1.cif.gz_A Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)	1.588E-11	1.000	322	16	297	443	18	268	289	295	0.637	0.869
LOKIASV2_0185_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B	1j1b-assembly1.cif.gz_B Binary complex structure of human tau protein kinase I with AMPPNP	5.544E-11	1.000	322	14	294	443	32	321	364	319	0.634	0.797
LOKIASV2_0185_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	1.323E-10	1.000	321	16	288	443	3	231	236	286	0.616	0.970
LOKIASV2_0185_ESMFold_hypothetical_protein	5odt-assembly1.cif.gz_A	5odt-assembly1.cif.gz_A Aurora-A in complex with TACC3	6.180E-11	1.000	321	8	298	443	1	252	258	297	0.657	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	6bql-assembly1.cif.gz_A	6bql-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with TAE-226	2.453E-11	1.000	321	10	288	443	2	271	278	303	0.630	0.971
LOKIASV2_0185_ESMFold_hypothetical_protein	1xh9-assembly1.cif.gz_A	1xh9-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	9.042E-11	1.000	321	10	290	443	26	282	338	292	0.634	0.760
LOKIASV2_0185_ESMFold_hypothetical_protein	5o7i-assembly1.cif.gz_A	5o7i-assembly1.cif.gz_A ERK5 in complex with a pyrrole inhibitor	9.736E-12	1.000	321	16	306	443	2	304	340	330	0.657	0.891
LOKIASV2_0185_ESMFold_hypothetical_protein	7oam-assembly2.cif.gz_B	7oam-assembly2.cif.gz_B Kinase domain of MERTK in complex with compound 8	1.253E-10	1.000	320	16	306	443	12	250	250	307	0.657	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly3.cif.gz_C	7nzy-assembly3.cif.gz_C Crystal structure of human Casein Kinase I delta in complex with CGS-15943	2.158E-10	1.000	320	4	302	443	1	276	283	310	0.675	0.975
LOKIASV2_0185_ESMFold_hypothetical_protein	6cmj-assembly2.cif.gz_B	6cmj-assembly2.cif.gz_B Human CAMKK2 with GSK650393	1.124E-10	1.000	320	16	300	443	5	283	287	312	0.643	0.972
LOKIASV2_0185_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B	7jxy-assembly2.cif.gz_B Structure of TTBK1 kinase domain in complex with Compound 18	1.124E-10	1.000	320	1	300	443	1	277	288	314	0.677	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	2.200E-11	1.000	320	3	296	443	7	340	341	375	0.664	0.979
LOKIASV2_0185_ESMFold_hypothetical_protein	6gra-assembly1.cif.gz_A	6gra-assembly1.cif.gz_A Human AURKA bound to BRD-7880	1.397E-10	1.000	319	8	298	443	1	247	250	300	0.657	0.988
LOKIASV2_0185_ESMFold_hypothetical_protein	5k0x-assembly2.cif.gz_B	5k0x-assembly2.cif.gz_B Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC2541	6.180E-11	1.000	319	20	297	443	14	251	254	296	0.628	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B	6s75-assembly2.cif.gz_B Crystal structure of Nek7 bound to compound 51	3.716E-10	1.000	319	16	297	443	15	265	267	291	0.637	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_F	2wtk-assembly1.cif.gz_F Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	2.158E-10	1.000	319	11	299	443	1	252	268	292	0.652	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	5o0y-assembly1.cif.gz_A	5o0y-assembly1.cif.gz_A TLK2 kinase domain from human	3.049E-11	1.000	319	13	295	443	5	286	288	307	0.639	0.979
LOKIASV2_0185_ESMFold_hypothetical_protein	1yhw-assembly1.cif.gz_A	1yhw-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with one point mutations (K299R)	3.219E-11	1.000	319	16	292	443	22	274	293	289	0.625	0.863
LOKIASV2_0185_ESMFold_hypothetical_protein	6rcg-assembly1.cif.gz_A	6rcg-assembly1.cif.gz_A Crystal structure of Casein kinase 1 delta (CK1 delta) complexed with SR3029 inhibitor	1.397E-10	1.000	319	1	297	443	2	281	295	311	0.670	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A	2xmy-assembly1.cif.gz_A Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents	3.219E-11	1.000	319	16	298	443	4	285	295	319	0.639	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A	6fd3-assembly1.cif.gz_A Thiophosphorylated PAK3 kinase domain	8.271E-12	1.000	319	13	296	443	22	275	296	299	0.641	0.858
LOKIASV2_0185_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B	6kmh-assembly2.cif.gz_B The crystal structure of CASK/Mint1 complex	1.187E-10	1.000	319	16	300	443	8	276	315	296	0.643	0.854
LOKIASV2_0185_ESMFold_hypothetical_protein	4kb8-assembly5.cif.gz_A	4kb8-assembly5.cif.gz_A CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	1.736E-10	1.000	318	10	297	443	1	251	265	298	0.650	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A	8qlq-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310	7.834E-12	1.000	318	16	300	443	10	276	280	308	0.643	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	5okt-assembly2.cif.gz_B	5okt-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with IWP-2	2.158E-10	1.000	318	13	297	443	4	267	282	298	0.643	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	7p7g-assembly2.cif.gz_B	7p7g-assembly2.cif.gz_B Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 2 and 3	9.042E-11	1.000	318	16	297	443	3	271	283	296	0.637	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A	6t2w-assembly1.cif.gz_A Crystal structure of the CSF1R kinase domain with a dihydropurinone inhibitor (compound 4)	8.111E-11	1.000	318	16	296	443	34	303	304	295	0.634	0.888
LOKIASV2_0185_ESMFold_hypothetical_protein	5xvu-assembly3.cif.gz_C	5xvu-assembly3.cif.gz_C Crystal structure of the protein kinase CK2 catalytic domain from Plasmodium falciparum bound to ATP	1.974E-11	1.000	318	10	295	443	24	316	321	334	0.646	0.913
LOKIASV2_0185_ESMFold_hypothetical_protein	4dc2-assembly1.cif.gz_A	4dc2-assembly1.cif.gz_A Structure of PKC in Complex with a Substrate Peptide from Par-3	1.644E-10	1.000	318	10	297	443	1	275	329	308	0.650	0.836
LOKIASV2_0185_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A	5n1m-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule (5-chloro-2-methoxyphenyl)methanamine	1.124E-10	1.000	318	10	288	443	39	293	351	292	0.630	0.726
LOKIASV2_0185_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_B	3nie-assembly3.cif.gz_B Crystal Structure of PF11_0147	2.323E-11	1.000	318	10	298	443	6	311	367	343	0.652	0.834
LOKIASV2_0185_ESMFold_hypothetical_protein	3igo-assembly1.cif.gz_A	3igo-assembly1.cif.gz_A Crystal structure of Cryptosporidium parvum CDPK1, cgd3_920	5.544E-11	1.000	318	13	294	443	6	259	446	299	0.637	0.570
LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly2.cif.gz_C	4yga-assembly2.cif.gz_C CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	3.589E-11	1.000	318	13	299	443	5	263	449	301	0.648	0.577
LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly1.cif.gz_A	4wbo-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	7.834E-12	1.000	318	6	294	443	151	426	497	305	0.652	0.555
LOKIASV2_0185_ESMFold_hypothetical_protein	3d2k-assembly1.cif.gz_A	3d2k-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with [7-(2-{2-[3-(3-chloro-phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3-d]pyrimidin-1-yl]-acetic acid	5.149E-10	1.000	317	10	298	443	1	243	245	295	0.652	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	2.158E-10	1.000	317	8	298	443	1	253	261	297	0.657	0.969
LOKIASV2_0185_ESMFold_hypothetical_protein	4tw9-assembly1.cif.gz_B	4tw9-assembly1.cif.gz_B Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation	3.333E-10	1.000	317	8	297	443	1	273	289	300	0.655	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A	3zo4-assembly1.cif.gz_A The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors	5.251E-11	1.000	317	10	288	443	25	279	337	289	0.630	0.757
LOKIASV2_0185_ESMFold_hypothetical_protein	2gnf-assembly1.cif.gz_A	2gnf-assembly1.cif.gz_A Protein kinase A fivefold mutant model of Rho-kinase with Y-27632	3.049E-11	1.000	317	10	300	443	29	300	341	311	0.657	0.798
LOKIASV2_0185_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A	3pfq-assembly1.cif.gz_A Crystal Structure and Allosteric Activation of Protein Kinase C beta II	2.540E-10	1.000	317	16	280	443	196	437	523	271	0.598	0.463
LOKIASV2_0185_ESMFold_hypothetical_protein	4kba-assembly5.cif.gz_A	4kba-assembly5.cif.gz_A CK1d in complex with 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine inhibitor	1.702E-09	1.000	316	10	297	443	1	249	263	291	0.650	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A	5cvf-assembly1.cif.gz_A Crystal Structure of CK2alpha with Compound 5 bound	3.789E-11	1.000	316	16	298	443	37	322	325	325	0.639	0.880
LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly4.cif.gz_D	4wbo-assembly4.cif.gz_D Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	8.271E-12	1.000	316	6	294	443	144	419	491	307	0.652	0.562
LOKIASV2_0185_ESMFold_hypothetical_protein	6ccf-assembly1.cif.gz_A	6ccf-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with Hesperadin	3.049E-11	1.000	315	10	288	443	1	253	260	300	0.630	0.973
LOKIASV2_0185_ESMFold_hypothetical_protein	8stg-assembly2.cif.gz_B	8stg-assembly2.cif.gz_B Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations	1.187E-10	1.000	315	16	296	443	10	271	274	296	0.634	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_B	5ng2-assembly1.cif.gz_B Structure of RIP2K(D146N) with bound Staurosporine	2.540E-10	1.000	315	9	296	443	14	275	278	306	0.650	0.942
LOKIASV2_0185_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	8.733E-12	1.000	315	16	300	443	17	285	289	314	0.643	0.931
LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_A	4czt-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23	3.049E-11	1.000	315	3	294	443	1	270	294	301	0.659	0.918
LOKIASV2_0185_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A	5otl-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 29	7.275E-11	1.000	315	16	295	443	36	316	320	322	0.632	0.878
LOKIASV2_0185_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A	5clp-assembly1.cif.gz_A Crystal Structure of CK2alpha with 3,4-dichlorophenethylamine bound	5.544E-11	1.000	315	16	295	443	37	316	322	322	0.632	0.870
LOKIASV2_0185_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B	3a8x-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	8.111E-11	1.000	315	8	310	443	3	281	331	313	0.684	0.843
LOKIASV2_0185_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A	1q97-assembly1.cif.gz_A The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	2.888E-11	1.000	315	4	305	443	4	329	351	356	0.682	0.929
LOKIASV2_0185_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	4.973E-11	1.000	315	1	310	443	1	330	353	369	0.700	0.935
LOKIASV2_0185_ESMFold_hypothetical_protein	6qat-assembly2.cif.gz_C	6qat-assembly2.cif.gz_C Crystal structure of ULK2 in complexed with hesperadin	3.923E-10	1.000	314	8	292	443	1	256	257	297	0.643	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	5de2-assembly1.cif.gz_A	5de2-assembly1.cif.gz_A Structural mechanism of Nek7 activation by Nek9-induced dimerisation	7.953E-10	1.000	314	16	297	443	15	265	267	295	0.637	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	7z5n-assembly8.cif.gz_H	7z5n-assembly8.cif.gz_H Crystal structure of DYRK1A in complex with CX-4945	2.158E-10	1.000	314	3	289	443	14	302	307	329	0.648	0.941
LOKIASV2_0185_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A	5vhb-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitor	1.770E-11	1.000	314	10	308	443	21	298	328	317	0.675	0.848
LOKIASV2_0185_ESMFold_hypothetical_protein	4qpm-assembly2.cif.gz_B	4qpm-assembly2.cif.gz_B Structure of Bub1 kinase domain	5.853E-11	1.000	314	1	298	443	33	309	329	310	0.673	0.842
LOKIASV2_0185_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A	2b9f-assembly1.cif.gz_A Crystal structure of non-phosphorylated Fus3	4.710E-11	1.000	314	16	300	443	13	298	337	325	0.643	0.849
LOKIASV2_0185_ESMFold_hypothetical_protein	4fr4-assembly3.cif.gz_C	4fr4-assembly3.cif.gz_C Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	3.789E-11	1.000	314	8	294	443	3	269	344	299	0.648	0.776
LOKIASV2_0185_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A	1q99-assembly1.cif.gz_A Crystal structure of the Saccharomyces cerevisiae SR protein kinsae, Sky1p, complexed with the non-hydrolyzable ATP analogue, AMP-PNP	1.504E-11	1.000	314	3	305	443	4	332	354	357	0.684	0.929
LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly1.cif.gz_A	6cd6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with GSK650394	1.008E-10	1.000	313	16	288	443	4	257	264	289	0.616	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_A	5ng0-assembly1.cif.gz_A Structure of RIP2K(L294F) with bound AMPPCP	3.157E-10	1.000	313	9	296	443	13	269	274	304	0.650	0.938
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B	5ng0-assembly1.cif.gz_B Structure of RIP2K(L294F) with bound AMPPCP	3.519E-10	1.000	313	9	296	443	14	278	282	306	0.650	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D	4d2p-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	3.399E-11	1.000	313	16	301	443	11	262	317	292	0.646	0.795
LOKIASV2_0185_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2	3ag9-assembly3.cif.gz_B-2 Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012	8.111E-11	1.000	313	10	288	443	24	278	319	290	0.630	0.799
LOKIASV2_0185_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	2.540E-10	1.000	313	9	298	443	1	267	323	299	0.655	0.827
LOKIASV2_0185_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D	4mq1-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	8.564E-11	1.000	313	3	289	443	14	333	337	353	0.648	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	2.682E-10	1.000	313	3	265	443	1	239	367	270	0.594	0.651
LOKIASV2_0185_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A	5ezr-assembly1.cif.gz_A Crystal Structure of PVX_084705 bound to compound	9.547E-11	1.000	313	6	298	443	513	781	803	305	0.661	0.335
LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B	6s73-assembly2.cif.gz_B Crystal structure of Nek7 SRS mutant bound to compound 51	4.618E-10	1.000	312	16	297	443	15	266	268	289	0.637	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	3uyt-assembly5.cif.gz_D-2	3uyt-assembly5.cif.gz_D-2 crystal structure of ck1d with PF670462 from P1 crystal form	2.278E-10	1.000	312	13	297	443	4	253	268	294	0.643	0.933
LOKIASV2_0185_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A	4yzn-assembly1.cif.gz_A Humanized Roco4 bound to Compound 19	1.064E-10	1.000	312	10	293	443	3	268	269	306	0.641	0.989
LOKIASV2_0185_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_A	3a8w-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	4.460E-11	1.000	312	8	310	443	2	278	328	328	0.684	0.845
LOKIASV2_0185_ESMFold_hypothetical_protein	6eiq-assembly3.cif.gz_C	6eiq-assembly3.cif.gz_C DYRK1A in complex with XMD14-124	4.460E-11	1.000	312	3	295	443	14	332	333	356	0.661	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A	5n3d-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-(trifluoromethyl)benzenecarboximidamide	2.278E-10	1.000	312	10	288	443	38	292	350	292	0.630	0.729
LOKIASV2_0185_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A	6eh3-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp190	2.043E-10	1.000	312	10	288	443	41	295	353	291	0.630	0.722
LOKIASV2_0185_ESMFold_hypothetical_protein	4z84-assembly1.cif.gz_A	4z84-assembly1.cif.gz_A PKAB3 in complex with pyrrolidine inhibitor 34a	2.278E-10	1.000	311	10	288	443	25	279	337	290	0.630	0.757
LOKIASV2_0185_ESMFold_hypothetical_protein	5n1o-assembly1.cif.gz_A	5n1o-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-chloro-4-(chloromethyl)-5-hydroxyphenyl)ethan-1-one	2.278E-10	1.000	311	10	288	443	28	282	340	290	0.630	0.750
LOKIASV2_0185_ESMFold_hypothetical_protein	1xha-assembly1.cif.gz_A	1xha-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	6.526E-11	1.000	311	10	290	443	38	294	350	293	0.634	0.734
LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	2.158E-10	1.000	310	17	288	443	11	254	260	287	0.614	0.938
LOKIASV2_0185_ESMFold_hypothetical_protein	5vib-assembly1.cif.gz_A	5vib-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitors	1.008E-10	1.000	310	10	308	443	21	298	309	313	0.675	0.900
LOKIASV2_0185_ESMFold_hypothetical_protein	5a3x-assembly3.cif.gz_C	5a3x-assembly3.cif.gz_C DYRK1A in complex with hydroxy benzothiazole fragment	7.275E-11	1.000	310	3	295	443	15	331	334	354	0.661	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A	4jrn-assembly1.cif.gz_A ROP18 kinase domain in complex with AMP-PNP and sucrose	1.869E-11	1.000	310	14	304	443	57	348	349	324	0.657	0.837
LOKIASV2_0185_ESMFold_hypothetical_protein	7pie-assembly1.cif.gz_A	7pie-assembly1.cif.gz_A Protein kinase A catalytic subunit in complex with PKI5-24 and EN068	2.158E-10	1.000	310	8	281	443	39	284	352	282	0.619	0.699
LOKIASV2_0185_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B	6c83-assembly1.cif.gz_B Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP	2.405E-10	1.000	309	16	298	443	7	245	247	289	0.639	0.968
LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	3.923E-10	1.000	309	16	288	443	3	255	261	295	0.616	0.969
LOKIASV2_0185_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B	5cs6-assembly2.cif.gz_B Crystal Structure of CK2alpha with Compound 3 bound	8.564E-11	1.000	309	16	298	443	36	315	316	325	0.639	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_B	3a8w-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	1.644E-10	1.000	309	8	310	443	2	279	329	316	0.684	0.845
LOKIASV2_0185_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A	4wb6-assembly1.cif.gz_A Crystal structure of a L205R mutant of human cAMP-dependent protein kinase A (catalytic alpha subunit)	1.008E-10	1.000	309	10	288	443	26	280	338	291	0.630	0.754
LOKIASV2_0185_ESMFold_hypothetical_protein	5bx7-assembly1.cif.gz_A	5bx7-assembly1.cif.gz_A PKA in complex with a benzothiophene fragment compound.	1.253E-10	1.000	309	10	298	443	34	296	346	302	0.652	0.760
LOKIASV2_0185_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E	3qam-assembly1.cif.gz_E Crystal Structure of Glu208Ala mutant of catalytic subunit of cAMP-dependent protein kinase	4.001E-11	1.000	309	10	300	443	38	303	350	308	0.657	0.760
LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	6.526E-11	1.000	309	10	299	443	2	264	442	305	0.655	0.595
LOKIASV2_0185_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A	4uzh-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	3.716E-10	1.000	308	8	298	443	3	246	251	297	0.657	0.972
LOKIASV2_0185_ESMFold_hypothetical_protein	2wma-assembly2.cif.gz_C	2wma-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	6.060E-10	1.000	308	16	298	443	5	258	266	296	0.639	0.955
LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly4.cif.gz_D	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	8.564E-11	1.000	308	10	292	443	1	266	267	305	0.639	0.996
LOKIASV2_0185_ESMFold_hypothetical_protein	7xhy-assembly1.cif.gz_A	7xhy-assembly1.cif.gz_A Crystal structure of MerTK Kinase domain with BMS794833	5.251E-11	1.000	308	16	306	443	20	270	270	315	0.657	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	8bok-assembly1.cif.gz_A	8bok-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 11	1.323E-10	1.000	308	1	297	443	1	267	280	306	0.670	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	5okt-assembly1.cif.gz_A	5okt-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with IWP-2	4.618E-10	1.000	308	13	297	443	4	271	286	298	0.643	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	3.399E-11	1.000	308	16	297	443	8	280	294	305	0.637	0.929
LOKIASV2_0185_ESMFold_hypothetical_protein	5x27-assembly1.cif.gz_A	5x27-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with SKLB(5)	1.064E-10	1.000	308	16	301	443	16	273	302	297	0.646	0.854
LOKIASV2_0185_ESMFold_hypothetical_protein	1zrz-assembly1.cif.gz_A	1zrz-assembly1.cif.gz_A Crystal Structure of the Catalytic Domain of Atypical Protein Kinase C-iota	4.374E-10	1.000	308	10	281	443	1	248	312	282	0.614	0.795
LOKIASV2_0185_ESMFold_hypothetical_protein	5w91-assembly1.cif.gz_A	5w91-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor LZH118	8.111E-11	1.000	308	13	299	443	7	269	451	302	0.648	0.583
LOKIASV2_0185_ESMFold_hypothetical_protein	4uzd-assembly2.cif.gz_B	4uzd-assembly2.cif.gz_B SAR156497 an exquisitely selective inhibitor of Aurora kinases	1.064E-10	1.000	307	8	298	443	2	255	258	296	0.657	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	5k0k-assembly1.cif.gz_A	5k0k-assembly1.cif.gz_A Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC2434	1.008E-10	1.000	307	16	297	443	11	257	260	297	0.637	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A	7ako-assembly1.cif.gz_A Crystal structure of CHK1 kinase domain in complex with a CLASPIN phosphopeptide	5.436E-10	1.000	307	16	290	443	8	261	270	288	0.621	0.941
LOKIASV2_0185_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_A	2qnj-assembly1.cif.gz_A Kinase and Ubiquitin-associated domains of MARK3/Par-1	6.526E-11	1.000	307	16	299	443	13	266	318	292	0.641	0.799
LOKIASV2_0185_ESMFold_hypothetical_protein	3e87-assembly2.cif.gz_B	3e87-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	1.644E-10	1.000	307	10	300	443	2	270	323	302	0.657	0.833
LOKIASV2_0185_ESMFold_hypothetical_protein	3c50-assembly1.cif.gz_B	3c50-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 2.6A	4.001E-11	1.000	307	16	298	443	158	425	496	301	0.639	0.540
LOKIASV2_0185_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A	4ztr-assembly1.cif.gz_A Human Aurora A catalytic domain bound to FK1141	3.716E-10	1.000	306	16	298	443	7	247	249	291	0.639	0.968
LOKIASV2_0185_ESMFold_hypothetical_protein	6ccy-assembly1.cif.gz_A	6ccy-assembly1.cif.gz_A Crystal structure of Akt1 in complex with a selective inhibitor	8.866E-10	1.000	306	9	298	443	4	270	326	297	0.655	0.819
LOKIASV2_0185_ESMFold_hypothetical_protein	5lih-assembly1.cif.gz_A	5lih-assembly1.cif.gz_A Structure of a peptide-substrate bound to PKCiota core kinase domain	3.333E-10	1.000	306	10	298	443	2	262	326	298	0.652	0.801
LOKIASV2_0185_ESMFold_hypothetical_protein	7z5n-assembly5.cif.gz_E	7z5n-assembly5.cif.gz_E Crystal structure of DYRK1A in complex with CX-4945	5.544E-11	1.000	306	3	295	443	14	338	340	362	0.661	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	6erv-assembly1.cif.gz_A	6erv-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp013	3.333E-10	1.000	306	10	288	443	41	295	343	292	0.630	0.743
LOKIASV2_0185_ESMFold_hypothetical_protein	5t5t-assembly1.cif.gz_A	5t5t-assembly1.cif.gz_A AMPK bound to allosteric activator	4.080E-12	1.000	306	8	437	443	1	343	369	441	0.971	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_B	3n9x-assembly1.cif.gz_B Crystal structure of Map Kinase from plasmodium berghei, PB000659.00.0	1.504E-11	1.000	306	16	298	443	19	317	374	337	0.639	0.799
LOKIASV2_0185_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A	2w5b-assembly1.cif.gz_A Human Nek2 kinase ATPgammaS-bound	3.399E-11	1.000	305	16	287	443	6	257	271	283	0.614	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A	5fp6-assembly1.cif.gz_A Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1H-indol-3-yl)prop-2-yn-1-ol (AT17833) in an alternate binding site.	2.540E-10	1.000	305	16	298	443	4	272	278	317	0.639	0.968
LOKIASV2_0185_ESMFold_hypothetical_protein	3uyt-assembly6.cif.gz_C	3uyt-assembly6.cif.gz_C crystal structure of ck1d with PF670462 from P1 crystal form	1.935E-10	1.000	305	13	297	443	4	271	286	301	0.643	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A	4dit-assembly1.cif.gz_A Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor	4.876E-10	1.000	305	14	306	443	20	293	329	311	0.661	0.833
LOKIASV2_0185_ESMFold_hypothetical_protein	5byy-assembly1.cif.gz_A	5byy-assembly1.cif.gz_A ERK5 IN COMPLEX WITH SMALL MOLECULE	1.677E-11	1.000	305	16	306	443	7	301	338	332	0.657	0.873
LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E	4nif-assembly1.cif.gz_E Heterodimeric structure of ERK2 and RSK1	1.278E-11	1.000	305	3	306	443	3	327	348	355	0.686	0.934
LOKIASV2_0185_ESMFold_hypothetical_protein	3c4w-assembly1.cif.gz_B	3c4w-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.7A	9.547E-11	1.000	305	16	298	443	181	448	519	299	0.639	0.516
LOKIASV2_0185_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A	8jmx-assembly1.cif.gz_A The crystal structure of human aurka kinase domain in complex with AURKA-A2	3.716E-10	1.000	304	16	298	443	7	247	250	289	0.639	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	4kb8-assembly3.cif.gz_C	4kb8-assembly3.cif.gz_C CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	1.644E-10	1.000	304	13	297	443	1	263	277	298	0.643	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B	8p7j-assembly2.cif.gz_B Crystal structure of MAP2K6 with a covalent compound GCL96	2.682E-10	1.000	304	16	300	443	9	264	279	300	0.643	0.918
LOKIASV2_0185_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A	7m2f-assembly1.cif.gz_A CDK2 with compound 14 inhibitor with carboxylate	1.644E-10	1.000	304	16	298	443	4	271	281	320	0.639	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B	5d7a-assembly2.cif.gz_B Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846	7.275E-11	1.000	304	16	305	443	15	277	286	307	0.655	0.920
LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly2.cif.gz_B	7nzy-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with CGS-15943	1.323E-10	1.000	304	16	302	443	8	279	286	306	0.648	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_A	4czu-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23 T190D mutant	5.853E-11	1.000	304	3	294	443	2	271	297	301	0.659	0.909
LOKIASV2_0185_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	9.042E-11	1.000	304	9	298	443	1	267	327	303	0.655	0.817
LOKIASV2_0185_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A	2f9g-assembly1.cif.gz_A Crystal structure of Fus3 phosphorylated on Tyr182	3.789E-11	1.000	304	16	298	443	13	291	332	323	0.639	0.840
LOKIASV2_0185_ESMFold_hypothetical_protein	4crs-assembly1.cif.gz_A	4crs-assembly1.cif.gz_A Human Protein Kinase N2 (PKN2, PRKCL2) in complex with ATPgammaS	1.229E-09	1.000	304	2	297	443	1	274	334	306	0.668	0.820
LOKIASV2_0185_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A	1q24-assembly1.cif.gz_A PKA double mutant model of PKB in complex with MgATP	5.251E-11	1.000	304	10	308	443	25	302	337	319	0.675	0.825
LOKIASV2_0185_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A	4h3q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	5.853E-11	1.000	304	3	309	443	4	318	352	349	0.693	0.895
LOKIASV2_0185_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A	4uzd-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	1.323E-10	1.000	303	16	298	443	7	252	254	289	0.639	0.969
LOKIASV2_0185_ESMFold_hypothetical_protein	4c3p-assembly1.cif.gz_D	4c3p-assembly1.cif.gz_D Structure of dephosphorylated Aurora A (122-403) bound to TPX2 and AMPPCP	1.935E-10	1.000	303	8	298	443	2	256	260	302	0.657	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B	2wtv-assembly2.cif.gz_B Aurora-A Inhibitor Structure	2.278E-10	1.000	303	16	298	443	8	261	264	290	0.639	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	7vto-assembly2.cif.gz_B	7vto-assembly2.cif.gz_B The crystal structure of PAK1 with the inhibitor GW8510	1.187E-10	1.000	303	16	296	443	16	258	278	288	0.634	0.874
LOKIASV2_0185_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A	5kz8-assembly1.cif.gz_A Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	4.876E-10	1.000	303	16	292	443	6	244	302	286	0.625	0.791
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_D	4d2v-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	5.251E-11	1.000	303	16	301	443	9	259	318	296	0.646	0.789
LOKIASV2_0185_ESMFold_hypothetical_protein	6eir-assembly2.cif.gz_B	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	1.253E-10	1.000	303	4	289	443	17	330	335	350	0.646	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A	1q5k-assembly1.cif.gz_A crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	2.405E-10	1.000	303	14	294	443	20	304	345	315	0.634	0.826
LOKIASV2_0185_ESMFold_hypothetical_protein	1o9u-assembly1.cif.gz_A-2	1o9u-assembly1.cif.gz_A-2 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE	3.519E-10	1.000	303	14	294	443	20	309	350	322	0.634	0.829
LOKIASV2_0185_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A	4o0u-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	4.876E-10	1.000	302	8	298	443	1	254	259	298	0.657	0.981
LOKIASV2_0185_ESMFold_hypothetical_protein	7s47-assembly1.cif.gz_A	7s47-assembly1.cif.gz_A Integrin beta5(743-774)-linker-PAK4cat(D440N/S474E)	1.253E-10	1.000	302	5	297	443	14	274	290	307	0.661	0.900
LOKIASV2_0185_ESMFold_hypothetical_protein	1yhv-assembly1.cif.gz_A	1yhv-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E)	5.251E-11	1.000	302	16	300	443	22	290	293	310	0.643	0.918
LOKIASV2_0185_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	1.323E-10	1.000	302	10	288	443	25	279	330	294	0.630	0.773
LOKIASV2_0185_ESMFold_hypothetical_protein	2gnj-assembly1.cif.gz_A	2gnj-assembly1.cif.gz_A PKA three fold mutant model of Rho-kinase with Y-27632	1.736E-10	1.000	302	10	298	443	25	286	337	306	0.652	0.777
LOKIASV2_0185_ESMFold_hypothetical_protein	3c4x-assembly1.cif.gz_B	3c4x-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	8.111E-11	1.000	302	6	297	443	140	425	475	313	0.659	0.602
LOKIASV2_0185_ESMFold_hypothetical_protein	4m3q-assembly1.cif.gz_A	4m3q-assembly1.cif.gz_A Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1917	3.157E-10	1.000	301	16	297	443	10	242	243	297	0.637	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	6ccf-assembly2.cif.gz_B	6ccf-assembly2.cif.gz_B Crystal Structure of the Human CAMKK1A in complex with Hesperadin	4.460E-11	1.000	301	10	288	443	1	255	262	299	0.630	0.973
LOKIASV2_0185_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B	4fg9-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	2.158E-10	1.000	301	16	295	443	7	240	279	291	0.632	0.839
LOKIASV2_0185_ESMFold_hypothetical_protein	5lqf-assembly2.cif.gz_D	5lqf-assembly2.cif.gz_D CDK1/CyclinB1/CKS2 in complex with NU6102	1.253E-10	1.000	301	16	298	443	7	285	285	321	0.639	0.979
LOKIASV2_0185_ESMFold_hypothetical_protein	2vu3-assembly1.cif.gz_A	2vu3-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	2.043E-10	1.000	301	16	298	443	4	275	285	317	0.639	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_D	4czu-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23 T190D mutant	3.219E-11	1.000	301	11	294	443	9	271	302	298	0.641	0.871
LOKIASV2_0185_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A	6a1c-assembly1.cif.gz_A Crystal structure of the CK2a1-go289 complex	9.736E-12	1.000	301	16	307	443	38	333	334	334	0.659	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	4nct-assembly5.cif.gz_B	4nct-assembly5.cif.gz_B Human DYRK1A in complex with PKC412	1.736E-10	1.000	301	4	296	443	17	333	334	356	0.661	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	3fhi-assembly1.cif.gz_A	3fhi-assembly1.cif.gz_A Crystal structure of a complex between the catalytic and regulatory (RI{alpha}) subunits of PKA	2.831E-10	1.000	301	10	288	443	26	280	338	290	0.630	0.754
LOKIASV2_0185_ESMFold_hypothetical_protein	3cok-assembly1.cif.gz_A	3cok-assembly1.cif.gz_A Crystal structure of PLK4 kinase	8.866E-10	1.000	300	16	296	443	13	233	234	283	0.634	0.944
LOKIASV2_0185_ESMFold_hypothetical_protein	4g34-assembly1.cif.gz_A	4g34-assembly1.cif.gz_A Crystal Structure of GSK6924 Bound to PERK (R587-R1092, delete A660-T867) at 2.70 A Resolution	3.519E-10	1.000	300	16	287	443	7	241	248	283	0.614	0.948
LOKIASV2_0185_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A	1zys-assembly1.cif.gz_A Co-crystal structure of Checkpoint Kinase Chk1 with a pyrrolo-pyridine inhibitor	1.527E-09	1.000	300	16	288	443	7	258	271	286	0.616	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B	7p6n-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH COMPOUND 12	7.953E-10	1.000	300	10	281	443	63	308	385	280	0.614	0.639
LOKIASV2_0185_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_A	6pme-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND	1.187E-10	1.000	299	5	296	443	1	266	268	305	0.659	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	6b16-assembly2.cif.gz_B	6b16-assembly2.cif.gz_B P21-activated kinase 1 in complex with a 4-azaindole inhibitor	1.397E-10	1.000	299	16	300	443	16	277	281	301	0.643	0.932
LOKIASV2_0185_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A	2fvd-assembly1.cif.gz_A Cyclin Dependent Kinase 2 (CDK2) with diaminopyrimidine inhibitor	5.740E-10	1.000	299	16	298	443	4	274	284	319	0.639	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	5w4w-assembly3.cif.gz_C	5w4w-assembly3.cif.gz_C Identification and Profiling of a Selective and Brain Penetrant Radioligand for In Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors	2.405E-10	1.000	299	13	297	443	4	270	284	298	0.643	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	2itt-assembly1.cif.gz_A	2itt-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with AEE788	4.973E-11	1.000	299	10	301	443	11	273	302	305	0.659	0.871
LOKIASV2_0185_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C	7cga-assembly3.cif.gz_C Crystal structure of human unphosphorylated p38gamma	1.146E-11	1.000	299	3	309	443	1	318	347	356	0.693	0.916
LOKIASV2_0185_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	1.557E-10	1.000	299	9	305	443	55	340	390	319	0.670	0.733
LOKIASV2_0185_ESMFold_hypothetical_protein	3c4z-assembly1.cif.gz_A-2	3c4z-assembly1.cif.gz_A-2 Crystal structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 1.84A	1.253E-10	1.000	299	16	290	443	154	416	493	292	0.621	0.533
LOKIASV2_0185_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	2.831E-10	1.000	298	16	299	443	6	251	253	293	0.641	0.972
LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	1.935E-10	1.000	298	16	287	443	3	248	256	296	0.614	0.961
LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly3.cif.gz_C	6cd6-assembly3.cif.gz_C Crystal Structure of the Human CAMKK1A in complex with GSK650394	6.180E-11	1.000	298	11	288	443	1	258	265	297	0.628	0.974
LOKIASV2_0185_ESMFold_hypothetical_protein	3g33-assembly1.cif.gz_C	3g33-assembly1.cif.gz_C Crystal structure of CDK4/cyclin D3	1.833E-10	1.000	298	16	289	443	2	287	291	313	0.619	0.983
LOKIASV2_0185_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A	7aj8-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 25	1.064E-10	1.000	298	3	295	443	1	327	330	364	0.661	0.991
LOKIASV2_0185_ESMFold_hypothetical_protein	3qkm-assembly1.cif.gz_A	3qkm-assembly1.cif.gz_A Spirocyclic sulfonamides as AKT inhibitors	2.990E-10	1.000	298	9	298	443	1	267	330	299	0.655	0.809
LOKIASV2_0185_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A	6jkm-assembly1.cif.gz_A Crystal structure of BubR1 kinase domain	7.682E-11	1.000	298	1	299	443	34	319	334	325	0.675	0.856
LOKIASV2_0185_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A	5ntj-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compound RKp032	2.158E-10	1.000	298	10	288	443	41	295	350	291	0.630	0.729
LOKIASV2_0185_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A	6yqj-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with open-chain Fasudil-derivative 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium (soaked)	2.043E-10	1.000	298	10	297	443	38	308	350	306	0.650	0.774
LOKIASV2_0185_ESMFold_hypothetical_protein	4xey-assembly2.cif.gz_B	4xey-assembly2.cif.gz_B Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase	7.682E-11	1.000	298	16	297	443	106	354	359	296	0.637	0.694
LOKIASV2_0185_ESMFold_hypothetical_protein	8fe2-assembly2.cif.gz_B	8fe2-assembly2.cif.gz_B Structure of J-PKAc chimera complexed with Aplithianine A	3.333E-10	1.000	298	16	290	443	96	347	400	286	0.621	0.630
LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A	4yga-assembly1.cif.gz_A CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	1.397E-10	1.000	298	14	299	443	6	263	448	308	0.646	0.576
LOKIASV2_0185_ESMFold_hypothetical_protein	4l9i-assembly1.cif.gz_A	4l9i-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Paroxetine	3.219E-11	1.000	298	6	298	443	149	425	504	312	0.661	0.550
LOKIASV2_0185_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B	2c6e-assembly2.cif.gz_B Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	1.297E-09	1.000	297	16	299	443	7	244	246	288	0.641	0.967
LOKIASV2_0185_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B	5wdy-assembly2.cif.gz_B Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	3.789E-11	1.000	297	14	287	443	14	252	259	289	0.619	0.923
LOKIASV2_0185_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	2.084E-11	1.000	297	13	297	443	19	273	295	306	0.643	0.864
LOKIASV2_0185_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C	6ej4-assembly3.cif.gz_C DYRK1A in complex with XMD7-112	6.526E-11	1.000	297	3	295	443	14	331	332	354	0.661	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B	1q5k-assembly1.cif.gz_B crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	2.540E-10	1.000	297	14	294	443	20	303	344	317	0.634	0.826
LOKIASV2_0185_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A	3i7b-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1	1.935E-10	1.000	297	13	299	443	4	266	459	302	0.648	0.573
LOKIASV2_0185_ESMFold_hypothetical_protein	8boc-assembly1.cif.gz_A	8boc-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 19	4.374E-10	1.000	296	1	297	443	1	260	271	306	0.670	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A	1csn-assembly1.cif.gz_A BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP	1.187E-10	1.000	296	16	301	443	7	282	293	309	0.646	0.942
LOKIASV2_0185_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	6.399E-10	1.000	296	16	300	443	6	247	300	293	0.643	0.807
LOKIASV2_0185_ESMFold_hypothetical_protein	4otd-assembly1.cif.gz_A	4otd-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain	7.532E-10	1.000	296	8	297	443	4	281	336	313	0.655	0.827
LOKIASV2_0185_ESMFold_hypothetical_protein	4f0g-assembly1.cif.gz_A	4f0g-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain from D. discoideum	1.297E-09	1.000	295	16	293	443	11	262	263	294	0.628	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A	4f0f-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain bound to AppCp from D. discoideum	1.736E-10	1.000	295	16	293	443	10	275	276	300	0.628	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	8p7j-assembly1.cif.gz_A	8p7j-assembly1.cif.gz_A Crystal structure of MAP2K6 with a covalent compound GCL96	9.885E-10	1.000	295	16	300	443	9	262	277	300	0.643	0.917
LOKIASV2_0185_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A	7s85-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound WN316	3.716E-10	1.000	295	16	298	443	2	271	281	321	0.639	0.961
LOKIASV2_0185_ESMFold_hypothetical_protein	1cki-assembly1.cif.gz_B	1cki-assembly1.cif.gz_B RECOMBINANT CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317	2.004E-09	1.000	295	8	297	443	1	272	286	307	0.655	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	6pxp-assembly3.cif.gz_A	6pxp-assembly3.cif.gz_A Human Casein Kinase 1 delta Site 2 mutant (K171E)	6.060E-10	1.000	295	3	297	443	1	274	288	309	0.666	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	3v04-assembly1.cif.gz_A	3v04-assembly1.cif.gz_A Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.	2.278E-10	1.000	295	8	300	443	1	272	289	311	0.661	0.941
LOKIASV2_0185_ESMFold_hypothetical_protein	3fy0-assembly1.cif.gz_A	3fy0-assembly1.cif.gz_A Crystal structure of PAK1 kinase domain with ruthenium complex DW1	8.111E-11	1.000	295	20	296	443	26	274	293	293	0.625	0.850
LOKIASV2_0185_ESMFold_hypothetical_protein	1syk-assembly2.cif.gz_B	1syk-assembly2.cif.gz_B Crystal structure of E230Q mutant of cAMP-dependent protein kinase reveals unexpected apoenzyme conformation	2.682E-10	1.000	295	10	300	443	26	295	325	306	0.657	0.831
LOKIASV2_0185_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B	6s11-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	1.557E-10	1.000	295	3	295	443	13	328	330	357	0.661	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A	5o5m-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp117	5.740E-10	1.000	295	10	290	443	30	286	340	295	0.634	0.756
LOKIASV2_0185_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A	2qur-assembly1.cif.gz_A Crystal Structure of F327A/K285P Mutant of cAMP-dependent Protein Kinase	1.323E-10	1.000	295	10	308	443	28	305	340	314	0.675	0.818
LOKIASV2_0185_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	5.149E-10	1.000	295	10	302	443	2	286	357	311	0.661	0.798
LOKIASV2_0185_ESMFold_hypothetical_protein	4pni-assembly1.cif.gz_A-2	4pni-assembly1.cif.gz_A-2 Bovine G protein-coupled receptor kinase 1 in complex with GSK2163632A	3.399E-11	1.000	295	16	298	443	158	425	492	301	0.639	0.545
LOKIASV2_0185_ESMFold_hypothetical_protein	4wnk-assembly1.cif.gz_A	4wnk-assembly1.cif.gz_A Crystal Structure of Bovine G Protein Coupled-Receptor Kinase 5 in Complex with CCG215022	7.275E-11	1.000	295	6	297	443	154	436	499	317	0.659	0.567
LOKIASV2_0185_ESMFold_hypothetical_protein	3nyn-assembly1.cif.gz_A	3nyn-assembly1.cif.gz_A Crystal Structure of G Protein-Coupled Receptor Kinase 6 in Complex with Sangivamycin	2.278E-10	1.000	295	6	297	443	176	455	553	308	0.659	0.506
LOKIASV2_0185_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A	4x7h-assembly1.cif.gz_A Co-crystal Structure of PERK bound to N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxamide inhibitor	7.532E-10	1.000	294	16	291	443	9	246	256	288	0.623	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	1r1w-assembly1.cif.gz_A	1r1w-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET	1.253E-10	1.000	294	16	297	443	27	270	287	292	0.637	0.850
LOKIASV2_0185_ESMFold_hypothetical_protein	6gro-assembly1.cif.gz_A	6gro-assembly1.cif.gz_A Human CSNK1G3 bound to SB-223133	3.157E-10	1.000	294	16	304	443	7	284	293	305	0.652	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	6uip-assembly1.cif.gz_A	6uip-assembly1.cif.gz_A DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.	1.323E-10	1.000	294	4	295	443	19	344	345	362	0.659	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	1.935E-10	1.000	293	14	295	443	14	264	266	297	0.637	0.944
LOKIASV2_0185_ESMFold_hypothetical_protein	5cen-assembly1.cif.gz_A	5cen-assembly1.cif.gz_A Crystal structure of DLK (kinase domain)	8.111E-11	1.000	293	1	297	443	1	254	281	304	0.670	0.904
LOKIASV2_0185_ESMFold_hypothetical_protein	3r9o-assembly1.cif.gz_A	3r9o-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-143	5.436E-10	1.000	293	16	298	443	4	272	282	317	0.639	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	9.885E-10	1.000	293	16	300	443	3	247	300	293	0.643	0.817
LOKIASV2_0185_ESMFold_hypothetical_protein	5ih9-assembly1.cif.gz_A	5ih9-assembly1.cif.gz_A MELK in complex with NVS-MELK8A	2.831E-10	1.000	293	16	301	443	10	250	308	295	0.646	0.782
LOKIASV2_0185_ESMFold_hypothetical_protein	6dd4-assembly4.cif.gz_D	6dd4-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	3.333E-10	1.000	293	3	304	443	1	306	311	332	0.682	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A	1o6k-assembly1.cif.gz_A Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP	4.618E-10	1.000	293	10	295	443	2	263	318	291	0.646	0.824
LOKIASV2_0185_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A	4h3p-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	1.349E-11	1.000	293	1	304	443	8	305	342	344	0.686	0.871
LOKIASV2_0185_ESMFold_hypothetical_protein	5cyz-assembly1.cif.gz_A	5cyz-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 1	1.008E-10	1.000	293	9	296	443	3	279	369	309	0.650	0.751
LOKIASV2_0185_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A	4fi1-assembly1.cif.gz_A Crystal structure of scCK2 alpha in complex with ATP	5.544E-11	1.000	293	16	305	443	40	370	371	370	0.655	0.892
LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly4.cif.gz_G	4yga-assembly4.cif.gz_G CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	2.278E-10	1.000	293	13	299	443	5	263	447	303	0.648	0.579
LOKIASV2_0185_ESMFold_hypothetical_protein	5w8r-assembly1.cif.gz_A	5w8r-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor 3CIB-PPI	2.682E-10	1.000	293	13	299	443	6	268	456	301	0.648	0.577
LOKIASV2_0185_ESMFold_hypothetical_protein	4l9i-assembly1.cif.gz_B	4l9i-assembly1.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Paroxetine	2.453E-11	1.000	293	16	297	443	157	433	493	307	0.637	0.562
LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly3.cif.gz_C	3op5-assembly3.cif.gz_C Human vaccinia-related kinase 1	1.935E-10	1.000	292	3	304	443	1	303	308	334	0.682	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A	7aj5-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 10	2.043E-10	1.000	292	4	295	443	1	327	330	364	0.659	0.991
LOKIASV2_0185_ESMFold_hypothetical_protein	2j50-assembly2.cif.gz_B	2j50-assembly2.cif.gz_B Structure of Aurora-2 in complex with PHA-739358	1.612E-09	1.000	291	10	299	443	1	247	249	296	0.655	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B	4zy6-assembly2.cif.gz_B Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29	2.158E-10	1.000	291	16	300	443	16	276	280	302	0.643	0.932
LOKIASV2_0185_ESMFold_hypothetical_protein	7ozd-assembly1.cif.gz_AAA	7ozd-assembly1.cif.gz_AAA FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.	1.557E-10	1.000	291	20	296	443	1	276	282	315	0.625	0.979
LOKIASV2_0185_ESMFold_hypothetical_protein	6nyb-assembly1.cif.gz_B	6nyb-assembly1.cif.gz_B Structure of a MAPK pathway complex	1.397E-10	1.000	291	6	300	443	4	271	289	309	0.666	0.927
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_B	4d2v-assembly1.cif.gz_B Structure of MELK in complex with inhibitors	1.323E-10	1.000	291	16	301	443	10	258	322	295	0.646	0.773
LOKIASV2_0185_ESMFold_hypothetical_protein	6npz-assembly2.cif.gz_B	6npz-assembly2.cif.gz_B Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	7.532E-10	1.000	291	9	298	443	4	270	323	299	0.655	0.827
LOKIASV2_0185_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A	2gu8-assembly1.cif.gz_A Discovery of 2-Pyrimidyl-5-Amidothiophenes as Novel and Potent Inhibitors for AKT: Synthesis and SAR Studies	5.544E-11	1.000	291	10	308	443	25	302	337	324	0.675	0.825
LOKIASV2_0185_ESMFold_hypothetical_protein	4aw2-assembly1.cif.gz_A-2	4aw2-assembly1.cif.gz_A-2 Crystal structure of CDC42 binding protein kinase alpha (MRCK alpha)	3.519E-10	1.000	291	9	296	443	70	352	398	320	0.650	0.711
LOKIASV2_0185_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	7.134E-10	1.000	290	16	290	443	8	237	241	293	0.621	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A	4x7j-assembly1.cif.gz_A Co-crystal Structure of PERK with 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor	7.953E-10	1.000	290	16	295	443	9	251	257	293	0.632	0.946
LOKIASV2_0185_ESMFold_hypothetical_protein	4kbk-assembly5.cif.gz_B-2	4kbk-assembly5.cif.gz_B-2 CK1d in complex with (3S)-3-{4-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]pyridin-2-yl}morpholine inhibitor	3.716E-10	1.000	290	10	302	443	1	283	289	312	0.661	0.979
LOKIASV2_0185_ESMFold_hypothetical_protein	2hak-assembly4.cif.gz_D	2hak-assembly4.cif.gz_D Catalytic and ubiqutin-associated domains of MARK1/PAR-1	4.142E-10	1.000	290	16	300	443	7	255	309	295	0.643	0.806
LOKIASV2_0185_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	5.436E-10	1.000	290	10	300	443	2	270	324	302	0.657	0.830
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_A	7p6n-assembly1.cif.gz_A ROCK2 IN COMPLEX WITH COMPOUND 12	8.866E-10	1.000	290	10	281	443	64	311	384	285	0.614	0.646
LOKIASV2_0185_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B	5uzj-assembly1.cif.gz_B Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	1.527E-09	1.000	290	9	291	443	66	326	386	296	0.639	0.676
LOKIASV2_0185_ESMFold_hypothetical_protein	5tc0-assembly1.cif.gz_A	5tc0-assembly1.cif.gz_A Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate	9.885E-10	1.000	289	16	297	443	10	237	238	295	0.637	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_D	7qq6-assembly2.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	1.736E-10	1.000	289	16	299	443	7	254	260	299	0.641	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	4zji-assembly1.cif.gz_A	4zji-assembly1.cif.gz_A PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	4.618E-10	1.000	289	16	292	443	17	258	278	286	0.625	0.871
LOKIASV2_0185_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A	3vn9-assembly1.cif.gz_A Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state	2.990E-10	1.000	289	10	294	443	5	274	291	303	0.643	0.928
LOKIASV2_0185_ESMFold_hypothetical_protein	3qkl-assembly1.cif.gz_A	3qkl-assembly1.cif.gz_A Spirochromane Akt Inhibitors	5.740E-10	1.000	289	9	297	443	1	266	318	298	0.652	0.836
LOKIASV2_0185_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E	1rdq-assembly1.cif.gz_E Hydrolysis of ATP in the crystal of Y204A mutant of cAMP-dependent protein kinase	2.990E-10	1.000	289	10	288	443	30	284	342	294	0.630	0.746
LOKIASV2_0185_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	2.405E-10	1.000	289	3	292	443	1	343	344	373	0.655	0.997
LOKIASV2_0185_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	2.043E-10	1.000	289	4	298	443	4	351	351	379	0.666	0.991
LOKIASV2_0185_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A	3o50-assembly1.cif.gz_A Crystal structure of benzamide 9 bound to AuroraA	2.932E-09	1.000	288	8	298	443	1	244	246	296	0.657	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H	7qwk-assembly8.cif.gz_H GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	2.831E-10	1.000	288	16	287	443	7	248	259	285	0.614	0.934
LOKIASV2_0185_ESMFold_hypothetical_protein	2cgu-assembly1.cif.gz_A	2cgu-assembly1.cif.gz_A Identification of chemically diverse Chk1 inhibitors by receptor- based virtual screening	2.630E-09	1.000	288	16	288	443	4	252	263	284	0.616	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	3.157E-10	1.000	288	16	295	443	11	269	271	296	0.632	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	1h08-assembly1.cif.gz_A	1h08-assembly1.cif.gz_A CDK2 in complex with a disubstituted 2, 4-bis anilino pyrimidine CDK4 inhibitor	4.374E-10	1.000	288	16	298	443	4	273	283	316	0.639	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	5osj-assembly1.cif.gz_A	5osj-assembly1.cif.gz_A Cdk2(WT) with covalent adduct at C177	3.519E-10	1.000	288	16	298	443	3	284	292	316	0.639	0.966
LOKIASV2_0185_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A	6yl6-assembly1.cif.gz_A Cdk2(F80C)	2.405E-10	1.000	288	16	298	443	9	293	303	316	0.639	0.941
LOKIASV2_0185_ESMFold_hypothetical_protein	5x28-assembly1.cif.gz_A	5x28-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with SKLB(6)	2.043E-10	1.000	288	16	310	443	16	281	310	308	0.666	0.858
LOKIASV2_0185_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B	5izj-assembly2.cif.gz_B Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	2.831E-10	1.000	288	10	288	443	25	279	327	297	0.630	0.780
LOKIASV2_0185_ESMFold_hypothetical_protein	7jnt-assembly1.cif.gz_B	7jnt-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	3.923E-10	1.000	288	10	307	443	65	315	376	307	0.673	0.668
LOKIASV2_0185_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B	6c9d-assembly2.cif.gz_B Crystal structure of KA1-autoinhibited MARK1 kinase	1.453E-12	1.000	288	16	437	443	8	403	422	477	0.953	0.938
LOKIASV2_0185_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	3.716E-10	1.000	287	9	295	443	1	254	256	301	0.648	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	3oxz-assembly1.cif.gz_A	3oxz-assembly1.cif.gz_A Crystal structure of ABL kinase domain bound with a DFG-out inhibitor AP24534	2.831E-10	1.000	287	16	297	443	15	256	268	297	0.637	0.903
LOKIASV2_0185_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B	1zmw-assembly1.cif.gz_B Catalytic and ubiqutin-associated domains of MARK2/PAR-1: T208A/S212A inactive double mutant	4.374E-10	1.000	287	16	301	443	6	251	302	293	0.646	0.815
LOKIASV2_0185_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C	6eis-assembly3.cif.gz_C DYRK1A in complex with JWC-055	1.397E-10	1.000	287	3	295	443	14	340	341	365	0.661	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A	6byr-assembly1.cif.gz_A Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PKAc alpha	1.935E-10	1.000	287	10	288	443	93	347	405	302	0.630	0.630
LOKIASV2_0185_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A	4mvf-assembly1.cif.gz_A Crystal Structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine	4.618E-10	1.000	287	8	299	443	5	231	408	296	0.659	0.556
LOKIASV2_0185_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	1.797E-09	1.000	286	16	280	443	8	237	252	275	0.598	0.913
LOKIASV2_0185_ESMFold_hypothetical_protein	3dbf-assembly1.cif.gz_A	3dbf-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 562	4.528E-09	1.000	286	2	298	443	1	245	261	308	0.670	0.939
LOKIASV2_0185_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2	2cn5-assembly1.cif.gz_A-2 Crystal structure of human Chk2 in complex with ADP	2.990E-10	1.000	286	13	300	443	11	269	283	302	0.650	0.915
LOKIASV2_0185_ESMFold_hypothetical_protein	3e8n-assembly1.cif.gz_A	3e8n-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) complexed with a potent inhibitor RDEA119 and MgATP	2.682E-10	1.000	286	16	300	443	8	274	291	305	0.643	0.918
LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly1.cif.gz_A	3op5-assembly1.cif.gz_A Human vaccinia-related kinase 1	7.134E-10	1.000	286	4	304	443	3	315	320	332	0.679	0.978
LOKIASV2_0185_ESMFold_hypothetical_protein	1rej-assembly1.cif.gz_A	1rej-assembly1.cif.gz_A Crystal structure of cAMP-dependent protein kinase complexed with balanol analog 1	7.532E-10	1.000	286	10	300	443	23	286	335	302	0.657	0.788
LOKIASV2_0185_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	1.397E-10	1.000	286	3	292	443	15	355	356	373	0.655	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_C-3	7p6n-assembly2.cif.gz_C-3 ROCK2 IN COMPLEX WITH COMPOUND 12	8.397E-10	1.000	286	10	281	443	65	306	378	282	0.614	0.640
LOKIASV2_0185_ESMFold_hypothetical_protein	5t6i-assembly1.cif.gz_A	5t6i-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TGCDPK1 FROM TOXOPLASMA GONDII COMPLEXED WITH 5GB	3.519E-10	1.000	286	13	301	443	6	267	427	299	0.652	0.614
LOKIASV2_0185_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D	2bmc-assembly4.cif.gz_D Aurora-2 T287D T288D complexed with PHA-680632	6.060E-10	1.000	285	16	299	443	7	248	256	291	0.641	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_C	7qq6-assembly2.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	6.890E-11	1.000	285	16	280	443	7	250	267	286	0.598	0.914
LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_C	4czu-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23 T190D mutant	3.519E-10	1.000	285	16	297	443	5	262	281	293	0.637	0.918
LOKIASV2_0185_ESMFold_hypothetical_protein	2uzt-assembly1.cif.gz_A	2uzt-assembly1.cif.gz_A PKA structures of AKT, indazole-pyridine inhibitors	3.716E-10	1.000	285	10	297	443	24	294	336	309	0.650	0.807
LOKIASV2_0185_ESMFold_hypothetical_protein	4dg3-assembly1.cif.gz_E	4dg3-assembly1.cif.gz_E Crystal structure of R336A mutant of cAMP-dependent protein kinase with unphosphorylated turn motif.	3.716E-10	1.000	285	10	288	443	25	279	337	296	0.630	0.757
LOKIASV2_0185_ESMFold_hypothetical_protein	4f1m-assembly1.cif.gz_A	4f1m-assembly1.cif.gz_A Crystal Structure of the G1179S Roco4 Kinase Domain bound to AppCp from D. discoideum.	1.044E-09	1.000	284	10	293	443	2	277	278	312	0.641	0.993
LOKIASV2_0185_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A	4wua-assembly1.cif.gz_A Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340	3.716E-10	1.000	284	3	296	443	1	343	344	373	0.664	0.997
LOKIASV2_0185_ESMFold_hypothetical_protein	6eh2-assembly1.cif.gz_A	6eh2-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp032 and AMP	1.702E-09	1.000	284	10	288	443	41	292	345	291	0.630	0.730
LOKIASV2_0185_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C	7jnt-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	5.436E-10	1.000	284	10	307	443	65	322	386	309	0.673	0.668
LOKIASV2_0185_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	6.756E-10	1.000	284	13	299	443	5	267	455	302	0.648	0.578
LOKIASV2_0185_ESMFold_hypothetical_protein	4umr-assembly1.cif.gz_A	4umr-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	3.923E-10	1.000	283	16	298	443	6	246	313	292	0.639	0.770
LOKIASV2_0185_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A	6una-assembly1.cif.gz_A Crystal structure of inactive p38gamma	1.475E-10	1.000	283	1	298	443	11	293	329	337	0.673	0.860
LOKIASV2_0185_ESMFold_hypothetical_protein	3nx8-assembly1.cif.gz_A	3nx8-assembly1.cif.gz_A human cAMP dependent protein kinase in complex with phenol	4.876E-10	1.000	283	10	297	443	24	283	335	304	0.650	0.776
LOKIASV2_0185_ESMFold_hypothetical_protein	1ydt-assembly1.cif.gz_E	1ydt-assembly1.cif.gz_E STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE	2.682E-10	1.000	283	10	288	443	24	278	336	300	0.630	0.759
LOKIASV2_0185_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A	7zks-assembly1.cif.gz_A SRPK1 IN COMPLEX WITH INHIBITOR	1.833E-10	1.000	283	4	298	443	4	348	348	381	0.666	0.991
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly3.cif.gz_E-4	7p6n-assembly3.cif.gz_E-4 ROCK2 IN COMPLEX WITH COMPOUND 12	1.297E-09	1.000	283	10	281	443	65	312	385	284	0.614	0.644
LOKIASV2_0185_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_A	4yve-assembly1.cif.gz_A ROCK 1 bound to methoxyphenyl thiazole inhibitor	7.953E-10	1.000	283	9	307	443	65	325	390	308	0.675	0.669
LOKIASV2_0185_ESMFold_hypothetical_protein	2vv9-assembly1.cif.gz_A	2vv9-assembly1.cif.gz_A CDK2 in complex with an imidazole piperazine	9.362E-10	1.000	282	16	298	443	4	269	279	316	0.639	0.953
LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B	4czt-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23	3.923E-10	1.000	282	16	299	443	10	269	286	291	0.641	0.909
LOKIASV2_0185_ESMFold_hypothetical_protein	3pj8-assembly1.cif.gz_A	3pj8-assembly1.cif.gz_A Structure of CDK2 in complex with a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine.	7.953E-10	1.000	282	16	298	443	5	278	288	316	0.639	0.951
LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_D	6s1f-assembly2.cif.gz_D Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	2.234E-09	1.000	282	20	297	443	18	268	288	294	0.628	0.872
LOKIASV2_0185_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A	6ylk-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK22 at F80C	6.756E-10	1.000	282	16	298	443	9	285	295	321	0.639	0.939
LOKIASV2_0185_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	9.885E-10	1.000	282	10	307	443	61	324	388	311	0.673	0.680
LOKIASV2_0185_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	3.847E-09	1.000	281	16	298	443	7	252	257	290	0.639	0.957
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G	7qwk-assembly7.cif.gz_G GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	1.612E-09	1.000	281	16	285	443	7	243	257	282	0.609	0.922
LOKIASV2_0185_ESMFold_hypothetical_protein	5osm-assembly1.cif.gz_A	5osm-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent adduct at C80	5.436E-10	1.000	281	16	298	443	8	284	292	317	0.639	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	6cqh-assembly2.cif.gz_B	6cqh-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	1.475E-10	1.000	281	3	291	443	1	299	316	328	0.652	0.946
LOKIASV2_0185_ESMFold_hypothetical_protein	6bu6-assembly4.cif.gz_D	6bu6-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a bis-difluorophenol-aminopyridine inhibitor	5.740E-10	1.000	281	3	304	443	1	313	318	340	0.682	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B	4mq2-assembly2.cif.gz_B The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	1.064E-10	1.000	281	4	295	443	15	337	339	360	0.659	0.953
LOKIASV2_0185_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A	5czo-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	2.540E-10	1.000	281	9	296	443	3	277	374	306	0.650	0.735
LOKIASV2_0185_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A	2hw6-assembly1.cif.gz_A Crystal structure of Mnk1 catalytic domain	2.932E-09	1.000	280	16	295	443	10	239	242	300	0.632	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_B	4d28-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK24/SOS2	1.229E-09	1.000	280	16	294	443	5	255	277	286	0.630	0.906
LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_D	4czt-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23	1.935E-10	1.000	280	16	286	443	13	261	302	281	0.612	0.825
LOKIASV2_0185_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A	6egw-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp017 and RKp117	3.519E-10	1.000	280	10	300	443	26	296	336	311	0.657	0.807
LOKIASV2_0185_ESMFold_hypothetical_protein	3f7z-assembly2.cif.gz_B	3f7z-assembly2.cif.gz_B X-ray Co-Crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor	1.297E-09	1.000	280	14	294	443	21	300	340	313	0.634	0.824
LOKIASV2_0185_ESMFold_hypothetical_protein	3krw-assembly1.cif.gz_A	3krw-assembly1.cif.gz_A Human GRK2 in complex with Gbetgamma subunits and balanol (soak)	9.929E-13	1.000	280	6	432	443	151	580	618	489	0.964	0.696
LOKIASV2_0185_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B	1zyd-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	8.397E-10	1.000	279	16	281	443	8	240	253	280	0.600	0.921
LOKIASV2_0185_ESMFold_hypothetical_protein	4lg4-assembly6.cif.gz_F	4lg4-assembly6.cif.gz_F Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	4.876E-10	1.000	279	16	305	443	10	253	276	302	0.655	0.884
LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_B	4czu-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23 T190D mutant	2.158E-10	1.000	279	16	297	443	11	268	287	302	0.637	0.899
LOKIASV2_0185_ESMFold_hypothetical_protein	4otg-assembly1.cif.gz_A	4otg-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib	1.102E-09	1.000	279	8	311	443	4	294	324	331	0.686	0.898
LOKIASV2_0185_ESMFold_hypothetical_protein	2h9v-assembly1.cif.gz_A	2h9v-assembly1.cif.gz_A Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y27632	8.866E-10	1.000	279	10	305	443	63	324	383	309	0.668	0.684
LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly2.cif.gz_B	6csw-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	1.102E-09	1.000	278	4	304	443	1	303	308	327	0.679	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	2jdo-assembly1.cif.gz_A	2jdo-assembly1.cif.gz_A STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE	5.149E-10	1.000	278	10	310	443	2	280	315	314	0.679	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D	3o7l-assembly1.cif.gz_D Crystal Structure of phospholamban (1-19):PKA C-subunit:AMP-PNP:Mg2+ complex	2.004E-09	1.000	278	10	300	443	26	297	335	307	0.657	0.812
LOKIASV2_0185_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E	3qal-assembly1.cif.gz_E Crystal Structure of Arg280Ala mutant of Catalytic subunit of cAMP-dependent Protein Kinase	5.149E-10	1.000	278	16	300	443	34	294	341	302	0.643	0.765
LOKIASV2_0185_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A	5xv7-assembly1.cif.gz_A SRPK1 in complex with Alectinib	2.405E-10	1.000	278	4	298	443	4	350	350	375	0.666	0.991
LOKIASV2_0185_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	2.405E-10	1.000	278	3	292	443	15	358	359	376	0.655	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C	5wng-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	4.289E-09	1.000	278	9	280	443	67	311	387	277	0.614	0.633
LOKIASV2_0185_ESMFold_hypothetical_protein	4uak-assembly1.cif.gz_A-2	4uak-assembly1.cif.gz_A-2 MRCK beta in complex with ADP	5.740E-10	1.000	278	16	281	443	78	330	404	285	0.600	0.626
LOKIASV2_0185_ESMFold_hypothetical_protein	3uzt-assembly1.cif.gz_A	3uzt-assembly1.cif.gz_A Structure of the C13.18 RNA Aptamer in Complex with G Protein-Coupled Receptor Kinase 2	1.619E-12	1.000	278	6	442	443	153	571	586	489	0.986	0.715
LOKIASV2_0185_ESMFold_hypothetical_protein	1muo-assembly1.cif.gz_A	1muo-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE	4.062E-09	1.000	277	16	299	443	6	249	251	288	0.641	0.972
LOKIASV2_0185_ESMFold_hypothetical_protein	3dv3-assembly1.cif.gz_A	3dv3-assembly1.cif.gz_A MEK1 with PF-04622664 Bound	8.397E-10	1.000	277	10	300	443	3	271	288	314	0.657	0.934
LOKIASV2_0185_ESMFold_hypothetical_protein	7n91-assembly1.cif.gz_A	7n91-assembly1.cif.gz_A P70 S6K1 IN COMPLEX WITH MSC2317067A-1	8.866E-10	1.000	277	16	297	443	7	251	307	291	0.637	0.798
LOKIASV2_0185_ESMFold_hypothetical_protein	6s1i-assembly3.cif.gz_C	6s1i-assembly3.cif.gz_C Crystal Structure of DYRK1A with small molecule inhibitor	3.333E-10	1.000	277	3	295	443	14	342	345	364	0.661	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B	1q97-assembly2.cif.gz_B The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	1.253E-10	1.000	277	3	309	443	2	343	361	368	0.693	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B	4yve-assembly1.cif.gz_B ROCK 1 bound to methoxyphenyl thiazole inhibitor	1.044E-09	1.000	277	9	307	443	66	330	393	315	0.675	0.674
LOKIASV2_0185_ESMFold_hypothetical_protein	3w10-assembly1.cif.gz_A	3w10-assembly1.cif.gz_A Aurora kinase A complexed to pyrazole aminoquinoline I	5.740E-10	1.000	276	16	297	443	8	259	263	294	0.637	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A	2bts-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032	1.229E-09	1.000	276	16	298	443	4	264	274	316	0.639	0.953
LOKIASV2_0185_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_B	4ynz-assembly1.cif.gz_B Structure of the N-terminal domain of SAD	2.004E-09	1.000	276	1	297	443	6	253	323	302	0.670	0.768
LOKIASV2_0185_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_B	3i6u-assembly1.cif.gz_B Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	1.527E-09	1.000	276	16	304	443	132	376	376	299	0.652	0.652
LOKIASV2_0185_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E	7jov-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	7.134E-10	1.000	276	10	307	443	65	324	385	313	0.673	0.675
LOKIASV2_0185_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A	6qft-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b	9.362E-10	1.000	275	5	300	443	1	260	276	313	0.668	0.942
LOKIASV2_0185_ESMFold_hypothetical_protein	3unk-assembly1.cif.gz_A	3unk-assembly1.cif.gz_A CDK2 in complex with inhibitor YL5-083	8.866E-10	1.000	275	16	298	443	4	285	295	318	0.639	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A	3vw8-assembly1.cif.gz_A Crystal structure of human c-Met kinase domain with its inhibitor	1.370E-09	1.000	275	16	297	443	38	294	303	297	0.637	0.848
LOKIASV2_0185_ESMFold_hypothetical_protein	4xbr-assembly1.cif.gz_A	4xbr-assembly1.cif.gz_A In cellulo Crystal Structure of PAK4 in complex with Inka	1.164E-09	1.000	275	5	297	443	40	300	316	312	0.661	0.826
LOKIASV2_0185_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2	4ual-assembly1.cif.gz_A-2 MRCK beta in complex with BDP00005290	1.527E-09	1.000	275	16	281	443	78	325	403	289	0.600	0.615
LOKIASV2_0185_ESMFold_hypothetical_protein	3cok-assembly2.cif.gz_B	3cok-assembly2.cif.gz_B Crystal structure of PLK4 kinase	2.116E-09	1.000	274	16	296	443	13	233	234	283	0.634	0.944
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C	7qwk-assembly3.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	9.362E-10	1.000	274	16	280	443	8	234	249	279	0.598	0.912
LOKIASV2_0185_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D	2vwi-assembly1.cif.gz_D Structure of the OSR1 kinase, a hypertension drug target	2.405E-10	1.000	274	16	292	443	12	278	284	302	0.625	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A	7s26-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G5018	2.932E-09	1.000	274	9	291	443	66	323	388	300	0.639	0.665
LOKIASV2_0185_ESMFold_hypothetical_protein	3k2l-assembly1.cif.gz_A	3k2l-assembly1.cif.gz_A Crystal Structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2)	2.682E-10	1.000	274	14	296	443	85	399	407	355	0.639	0.774
LOKIASV2_0185_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A	2xnm-assembly1.cif.gz_A Structure of NEK2 bound to CCT	7.953E-10	1.000	273	16	287	443	6	244	258	281	0.614	0.926
LOKIASV2_0185_ESMFold_hypothetical_protein	3r8m-assembly1.cif.gz_A	3r8m-assembly1.cif.gz_A CDK2 in complex with inhibitor L3-3	2.359E-09	1.000	273	16	298	443	4	276	286	317	0.639	0.955
LOKIASV2_0185_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B	5kz8-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	1.229E-09	1.000	273	16	364	443	6	286	300	361	0.788	0.937
LOKIASV2_0185_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	6.060E-10	1.000	273	1	295	443	1	348	350	381	0.666	0.994
LOKIASV2_0185_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	5.654E-12	1.000	273	8	437	443	1	415	441	479	0.971	0.941
LOKIASV2_0185_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	1.169E-12	1.000	273	6	442	443	153	601	628	505	0.986	0.715
LOKIASV2_0185_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	1.297E-09	1.000	272	16	298	443	3	280	286	316	0.639	0.972
LOKIASV2_0185_ESMFold_hypothetical_protein	3s0o-assembly1.cif.gz_A	3s0o-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-1-138	1.446E-09	1.000	272	16	298	443	4	283	293	317	0.639	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly3.cif.gz_C	6csw-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	1.612E-09	1.000	272	1	291	443	1	302	319	321	0.657	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	6c2y-assembly1.cif.gz_A	6c2y-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257142	1.805E-12	1.000	272	6	431	443	153	580	617	478	0.962	0.694
LOKIASV2_0185_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A	3d5v-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain.	4.289E-09	1.000	271	3	287	443	1	233	260	294	0.643	0.896
LOKIASV2_0185_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B	6nfy-assembly1.cif.gz_B Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	6.756E-10	1.000	271	13	300	443	8	275	285	308	0.650	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	4mao-assembly1.cif.gz_A	4mao-assembly1.cif.gz_A RSK2 T493M C-Terminal Kinase Domain in Complex with RMM58	1.229E-09	1.000	271	16	300	443	8	269	298	306	0.643	0.879
LOKIASV2_0185_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	4.618E-10	1.000	271	1	297	443	12	292	331	336	0.670	0.849
LOKIASV2_0185_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	9.885E-10	1.000	271	3	298	443	14	361	361	379	0.668	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly6.cif.gz_F	7qwk-assembly6.cif.gz_F GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	1.898E-09	1.000	270	16	280	443	7	238	254	285	0.598	0.913
LOKIASV2_0185_ESMFold_hypothetical_protein	2jii-assembly2.cif.gz_B	2jii-assembly2.cif.gz_B Structure of vaccinia related kinase 3	8.866E-10	1.000	270	1	307	443	13	326	326	349	0.693	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B	7qwk-assembly2.cif.gz_B GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	5.943E-09	1.000	269	16	280	443	8	240	249	277	0.598	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_D	1zyc-assembly2.cif.gz_D Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	1.164E-09	1.000	269	16	281	443	8	242	256	282	0.600	0.918
LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A	6s1f-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	1.797E-09	1.000	269	20	297	443	18	271	291	298	0.628	0.873
LOKIASV2_0185_ESMFold_hypothetical_protein	3e88-assembly2.cif.gz_B	3e88-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	1.898E-09	1.000	269	10	300	443	2	270	321	300	0.657	0.838
LOKIASV2_0185_ESMFold_hypothetical_protein	3t8o-assembly1.cif.gz_A	3t8o-assembly1.cif.gz_A Rhodopsin kinase (GRK1) L166K mutant at 2.5A resolution	1.424E-11	1.000	269	6	368	443	149	493	493	392	0.819	0.700
LOKIASV2_0185_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_C	2vwi-assembly1.cif.gz_C Structure of the OSR1 kinase, a hypertension drug target	3.923E-10	1.000	268	16	288	443	9	265	270	292	0.616	0.952
LOKIASV2_0185_ESMFold_hypothetical_protein	1v1k-assembly1.cif.gz_A	1v1k-assembly1.cif.gz_A CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR	4.289E-09	1.000	268	16	298	443	4	267	277	323	0.639	0.953
LOKIASV2_0185_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_G	3f5p-assembly17.cif.gz_G Complex Structure of Insulin-like Growth Factor Receptor and 3-Cyanoquinoline Inhibitor	2.116E-09	1.000	268	16	293	443	20	285	302	297	0.628	0.881
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_H-2	7p6n-assembly1.cif.gz_H-2 ROCK2 IN COMPLEX WITH COMPOUND 12	2.116E-09	1.000	268	10	281	443	63	293	366	283	0.614	0.631
LOKIASV2_0185_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G	7jov-assembly4.cif.gz_G CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	1.446E-09	1.000	268	10	312	443	65	333	388	321	0.684	0.693
LOKIASV2_0185_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_B	3tku-assembly1.cif.gz_B MRCK beta in complex with fasudil	1.297E-09	1.000	268	16	305	443	75	344	395	312	0.655	0.684
LOKIASV2_0185_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_B	5d9h-assembly1.cif.gz_B Crystal structure of SPAK (STK39) dimer in the basal activity state	9.885E-10	1.000	267	16	305	443	11	291	293	318	0.655	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	5.740E-10	1.000	267	16	309	443	12	267	313	304	0.664	0.818
LOKIASV2_0185_ESMFold_hypothetical_protein	7b9l-assembly2.cif.gz_B	7b9l-assembly2.cif.gz_B MEK1 in complex with compound 23	8.866E-10	1.000	266	6	300	443	19	280	296	313	0.666	0.885
LOKIASV2_0185_ESMFold_hypothetical_protein	7b9l-assembly1.cif.gz_A	7b9l-assembly1.cif.gz_A MEK1 in complex with compound 23	1.102E-09	1.000	266	6	300	443	27	282	299	306	0.666	0.856
LOKIASV2_0185_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B	7p1l-assembly2.cif.gz_B The MARK3 Kinase Domain Bound To AA-CS-1-008	2.004E-09	1.000	266	16	299	443	7	250	300	295	0.641	0.813
LOKIASV2_0185_ESMFold_hypothetical_protein	7b94-assembly1.cif.gz_A	7b94-assembly1.cif.gz_A MEK1 in complex with compound 6	1.044E-09	1.000	266	8	300	443	29	284	301	305	0.661	0.850
LOKIASV2_0185_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A	4lgd-assembly5.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	3.716E-10	1.000	266	16	298	443	12	265	350	294	0.639	0.726
LOKIASV2_0185_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_A	5uzj-assembly1.cif.gz_A Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	8.694E-09	1.000	266	9	291	443	65	323	387	296	0.639	0.669
LOKIASV2_0185_ESMFold_hypothetical_protein	3ncz-assembly2.cif.gz_C	3ncz-assembly2.cif.gz_C X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor	1.581E-08	1.000	266	9	291	443	65	325	389	292	0.639	0.671
LOKIASV2_0185_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	1.906E-12	1.000	266	6	431	443	153	579	616	482	0.962	0.693
LOKIASV2_0185_ESMFold_hypothetical_protein	5wg5-assembly1.cif.gz_A	5wg5-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224061	1.107E-12	1.000	266	6	432	443	149	582	617	490	0.964	0.703
LOKIASV2_0185_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A	3efw-assembly1.cif.gz_A Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	1.272E-08	1.000	265	8	298	443	1	238	240	300	0.657	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	3efw-assembly2.cif.gz_B	3efw-assembly2.cif.gz_B Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	1.141E-08	1.000	265	16	298	443	8	239	242	291	0.639	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D	7qwk-assembly4.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	2.004E-09	1.000	265	16	280	443	8	240	254	282	0.598	0.917
LOKIASV2_0185_ESMFold_hypothetical_protein	4zy5-assembly2.cif.gz_B	4zy5-assembly2.cif.gz_B Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17	3.923E-10	1.000	265	16	300	443	16	283	287	303	0.643	0.934
LOKIASV2_0185_ESMFold_hypothetical_protein	6hhj-assembly1.cif.gz_A	6hhj-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b	8.866E-10	1.000	265	8	298	443	109	376	410	300	0.657	0.654
LOKIASV2_0185_ESMFold_hypothetical_protein	3pvw-assembly1.cif.gz_A	3pvw-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and a selective kinase inhibitor (CMPD103A)	4.549E-12	1.000	265	6	432	443	154	578	613	495	0.964	0.693
LOKIASV2_0185_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	8.234E-09	1.000	264	10	295	443	2	238	270	291	0.646	0.878
LOKIASV2_0185_ESMFold_hypothetical_protein	2c47-assembly3.cif.gz_C	2c47-assembly3.cif.gz_C Structure of casein kinase 1 gamma 2	2.630E-09	1.000	264	30	297	443	9	264	283	283	0.605	0.905
LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_C	6s1f-assembly2.cif.gz_C Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	2.116E-09	1.000	264	20	297	443	18	270	289	298	0.628	0.875
LOKIASV2_0185_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A	2xh5-assembly1.cif.gz_A Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB	1.102E-09	1.000	264	10	310	443	2	280	317	315	0.679	0.880
LOKIASV2_0185_ESMFold_hypothetical_protein	2f49-assembly2.cif.gz_B	2f49-assembly2.cif.gz_B Crystal structure of Fus3 in complex with a Ste5 peptide	1.446E-09	1.000	264	16	298	443	13	296	337	326	0.639	0.843
LOKIASV2_0185_ESMFold_hypothetical_protein	3flw-assembly1.cif.gz_A	3flw-assembly1.cif.gz_A P38 kinase crystal structure in complex with pamapimod	1.124E-10	1.000	264	3	306	443	1	311	345	351	0.686	0.901
LOKIASV2_0185_ESMFold_hypothetical_protein	3fly-assembly1.cif.gz_A	3fly-assembly1.cif.gz_A P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-isopropylamino-8-methyl-8h-pyrido[2,3-d]pyrimidin-7-one	6.180E-11	1.000	264	8	306	443	6	313	347	350	0.675	0.888
LOKIASV2_0185_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A	5my8-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with SPHINX31	8.866E-10	1.000	264	4	298	443	7	355	355	380	0.666	0.983
LOKIASV2_0185_ESMFold_hypothetical_protein	3pvu-assembly1.cif.gz_A	3pvu-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and a selective kinase inhibitor (CMPD101)	3.109E-12	1.000	264	6	440	443	153	582	609	492	0.982	0.706
LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_D	3dak-assembly2.cif.gz_D Crystal Structure of Domain-Swapped OSR1 kinase domain	3.095E-09	1.000	263	4	292	443	1	281	284	315	0.652	0.989
LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_C	4czt-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23	5.740E-10	1.000	263	16	287	443	4	253	286	282	0.614	0.874
LOKIASV2_0185_ESMFold_hypothetical_protein	3ptg-assembly1.cif.gz_A	3ptg-assembly1.cif.gz_A Design and Synthesis of a Novel, Orally Efficacious Tri-substituted Thiophene Based JNK Inhibitor	2.043E-10	1.000	263	5	297	443	1	299	340	347	0.661	0.879
LOKIASV2_0185_ESMFold_hypothetical_protein	6ed6-assembly2.cif.gz_B	6ed6-assembly2.cif.gz_B Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	1.612E-09	1.000	263	10	307	443	60	305	364	309	0.673	0.676
LOKIASV2_0185_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_C	4d28-assembly2.cif.gz_C Crystal structure of the kinase domain of CIPK24/SOS2	3.644E-09	1.000	262	16	294	443	5	257	279	288	0.630	0.907
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukm-assembly1.cif.gz_A	5ukm-assembly1.cif.gz_A bovine GRK2 in complex with human Gbetagamma subunits and CCG258208 (14as)	3.466E-12	1.000	262	6	433	443	152	585	621	493	0.966	0.699
LOKIASV2_0185_ESMFold_hypothetical_protein	8x88-assembly3.cif.gz_A	8x88-assembly3.cif.gz_A The Crystal Structure of TNIK from Biortus.	9.362E-10	1.000	261	16	304	443	11	291	294	310	0.652	0.956
LOKIASV2_0185_ESMFold_hypothetical_protein	2onl-assembly1.cif.gz_A	2onl-assembly1.cif.gz_A Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	1.644E-10	1.000	261	8	306	443	6	304	338	349	0.675	0.885
LOKIASV2_0185_ESMFold_hypothetical_protein	5he0-assembly1.cif.gz_A	5he0-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG215022	3.109E-12	1.000	261	6	433	443	153	587	621	496	0.966	0.700
LOKIASV2_0185_ESMFold_hypothetical_protein	6u2g-assembly1.cif.gz_A	6u2g-assembly1.cif.gz_A BRAF-MEK complex with AMP-PCP bound to BRAF	2.776E-09	1.000	260	6	300	443	17	291	309	312	0.666	0.890
LOKIASV2_0185_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B	6bxi-assembly2.cif.gz_B X-ray crystal structure of NDR1 kinase domain	7.532E-10	1.000	260	9	299	443	1	312	332	339	0.657	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	2bal-assembly1.cif.gz_A	2bal-assembly1.cif.gz_A p38alpha MAP kinase bound to pyrazoloamine	7.532E-10	1.000	260	8	306	443	5	302	337	343	0.675	0.884
LOKIASV2_0185_ESMFold_hypothetical_protein	4loq-assembly3.cif.gz_C	4loq-assembly3.cif.gz_C Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound sulphate)	7.134E-10	1.000	260	8	294	443	6	295	337	324	0.648	0.861
LOKIASV2_0185_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_B	5kkt-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole piperazine inhibitor	1.446E-09	1.000	260	9	307	443	66	330	394	317	0.675	0.673
LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_C	3dak-assembly3.cif.gz_C Crystal Structure of Domain-Swapped OSR1 kinase domain	1.527E-09	1.000	259	16	292	443	11	278	281	302	0.625	0.954
LOKIASV2_0185_ESMFold_hypothetical_protein	3rcd-assembly1.cif.gz_A	3rcd-assembly1.cif.gz_A HER2 Kinase Domain Complexed with TAK-285	1.297E-09	1.000	259	14	301	443	12	256	281	301	0.650	0.872
LOKIASV2_0185_ESMFold_hypothetical_protein	4ark-assembly1.cif.gz_A	4ark-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH A SMALL MOLECULE INHIBITOR AND ADP	3.451E-09	1.000	259	16	300	443	8	274	291	304	0.643	0.918
LOKIASV2_0185_ESMFold_hypothetical_protein	1s9i-assembly1.cif.gz_B	1s9i-assembly1.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP	1.702E-09	1.000	259	2	300	443	1	275	291	319	0.675	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly3.cif.gz_C	5ukf-assembly3.cif.gz_C Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	3.095E-09	1.000	259	4	291	443	3	300	317	321	0.650	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	5dmz-assembly2.cif.gz_B	5dmz-assembly2.cif.gz_B Structure of human Bub1 kinase domain phosphorylated at Ser969	1.370E-09	1.000	259	1	298	443	37	318	340	323	0.673	0.829
LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	5.331E-09	1.000	259	4	291	443	4	346	348	373	0.650	0.986
LOKIASV2_0185_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A	3vud-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	2.990E-10	1.000	259	5	295	443	2	311	355	347	0.657	0.873
LOKIASV2_0185_ESMFold_hypothetical_protein	3vui-assembly1.cif.gz_A	3vui-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1	4.876E-10	1.000	259	5	297	443	2	313	355	350	0.661	0.879
LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_B	3dak-assembly3.cif.gz_B Crystal Structure of Domain-Swapped OSR1 kinase domain	6.995E-09	1.000	258	16	292	443	12	275	278	298	0.625	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	2.043E-10	1.000	258	16	308	443	5	293	298	335	0.661	0.970
LOKIASV2_0185_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A	3v5w-assembly1.cif.gz_A Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine	3.864E-12	1.000	258	6	432	443	153	588	623	490	0.964	0.700
LOKIASV2_0185_ESMFold_hypothetical_protein	7mf0-assembly1.cif.gz_AAA	7mf0-assembly1.cif.gz_AAA Co-crystal structure of PERK with inhibitor (R)-2-amino-N-cyclopropyl-5-(4-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-2-methylphenyl)nicotinamide	4.528E-09	1.000	257	16	291	443	8	255	259	294	0.623	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A	6qho-assembly1.cif.gz_A Dual specificity mitogen-activated protein kinase kinase 7 in complex with pyrazolopyrimidine 1a	8.234E-09	1.000	257	5	300	443	1	258	275	312	0.668	0.938
LOKIASV2_0185_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_C	1f3m-assembly1.cif.gz_C CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	9.885E-10	1.000	257	16	292	443	22	267	287	299	0.625	0.857
LOKIASV2_0185_ESMFold_hypothetical_protein	2c5y-assembly1.cif.gz_A	2c5y-assembly1.cif.gz_A DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN	4.528E-09	1.000	257	16	298	443	4	281	290	317	0.639	0.959
LOKIASV2_0185_ESMFold_hypothetical_protein	4d9u-assembly1.cif.gz_A	4d9u-assembly1.cif.gz_A Rsk2 C-terminal Kinase Domain, (E)-tert-butyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate	6.060E-10	1.000	257	16	300	443	15	276	307	303	0.643	0.853
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	1.424E-11	1.000	257	8	441	443	1	424	443	499	0.980	0.957
LOKIASV2_0185_ESMFold_hypothetical_protein	3uqc-assembly1.cif.gz_C	3uqc-assembly1.cif.gz_C Structure of the Intracellular Kinase Homology Domain of Rv3910 at 2.2 A resolution	3.205E-08	1.000	256	2	296	443	4	249	250	313	0.666	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	7m0z-assembly1.cif.gz_B	7m0z-assembly1.cif.gz_B Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and CH5126766	1.702E-09	1.000	256	8	300	443	20	292	310	318	0.661	0.881
LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly4.cif.gz_D	6csw-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	7.134E-10	1.000	256	3	291	443	1	295	312	326	0.652	0.946
LOKIASV2_0185_ESMFold_hypothetical_protein	5uu1-assembly1.cif.gz_A	5uu1-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to BI-D1870	7.134E-10	1.000	256	5	307	443	3	305	315	325	0.684	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	3lff-assembly1.cif.gz_A	3lff-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL166	3.519E-10	1.000	256	8	306	443	5	301	335	347	0.675	0.887
LOKIASV2_0185_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B	2hw6-assembly2.cif.gz_B Crystal structure of Mnk1 catalytic domain	2.875E-08	1.000	255	16	290	443	9	229	233	293	0.621	0.948
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A	7qwk-assembly1.cif.gz_A GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	3.095E-09	1.000	255	16	280	443	8	236	245	281	0.598	0.935
LOKIASV2_0185_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	1.612E-09	1.000	255	16	300	443	4	255	285	301	0.643	0.884
LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_D	4nif-assembly1.cif.gz_D Heterodimeric structure of ERK2 and RSK1	1.297E-09	1.000	255	16	300	443	6	264	313	303	0.643	0.827
LOKIASV2_0185_ESMFold_hypothetical_protein	6vxu-assembly2.cif.gz_B	6vxu-assembly2.cif.gz_B Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471	4.528E-09	1.000	254	4	304	443	1	300	305	341	0.679	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	6ncg-assembly1.cif.gz_A	6ncg-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to pyridin-benzenesulfonamide inhibitor	4.289E-09	1.000	254	3	294	443	1	298	308	335	0.659	0.968
LOKIASV2_0185_ESMFold_hypothetical_protein	5wg3-assembly1.cif.gz_A	5wg3-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258748	4.308E-12	1.000	254	6	433	443	153	583	618	480	0.966	0.697
LOKIASV2_0185_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A	4mk0-assembly1.cif.gz_A Crystal structure of G protein-coupled receptor kinase 2 in complex with a a rationally designed paroxetine derivative	5.354E-12	1.000	254	6	432	443	153	595	631	502	0.964	0.702
LOKIASV2_0185_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A	1mrv-assembly1.cif.gz_A crystal structure of an inactive Akt2 kinase domain	3.384E-08	1.000	253	10	295	443	1	229	261	292	0.646	0.877
LOKIASV2_0185_ESMFold_hypothetical_protein	3os3-assembly1.cif.gz_A	3os3-assembly1.cif.gz_A Mitogen-activated protein kinase kinase 1 (MEK1) in complex with CH4858061 and MgATP	1.205E-08	1.000	253	16	300	443	7	259	272	297	0.643	0.930
LOKIASV2_0185_ESMFold_hypothetical_protein	3p4k-assembly1.cif.gz_A	3p4k-assembly1.cif.gz_A The third conformation of p38a MAP kinase observed in phosphorylated p38a and in solution	3.157E-10	1.000	253	8	306	443	6	303	338	348	0.675	0.882
LOKIASV2_0185_ESMFold_hypothetical_protein	4yhj-assembly1.cif.gz_A	4yhj-assembly1.cif.gz_A Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4 (GRK4)	4.289E-09	1.000	253	6	306	443	154	423	501	312	0.679	0.539
LOKIASV2_0185_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	8.271E-12	1.000	253	6	440	443	152	594	621	493	0.982	0.713
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly1.cif.gz_D	5ng3-assembly1.cif.gz_D Structure of inactive kinase RIP2K(K47R)	1.023E-08	1.000	252	9	297	443	10	278	279	312	0.652	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_A	5dbx-assembly1.cif.gz_A Crystal structure of murine SPAK(T243D) in complex with AMPPNP	2.359E-09	1.000	252	16	305	443	10	281	284	315	0.655	0.958
LOKIASV2_0185_ESMFold_hypothetical_protein	3vvh-assembly2.cif.gz_B	3vvh-assembly2.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP	2.932E-09	1.000	252	10	300	443	3	273	290	313	0.657	0.934
LOKIASV2_0185_ESMFold_hypothetical_protein	6cmm-assembly2.cif.gz_B	6cmm-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	2.359E-09	1.000	252	4	304	443	1	305	310	344	0.679	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	6cnx-assembly2.cif.gz_B	6cnx-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor	3.268E-09	1.000	252	4	304	443	3	306	311	343	0.679	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	3e3p-assembly1.cif.gz_B	3e3p-assembly1.cif.gz_B Glycogen synthase kinase from Leishmania major	5.149E-10	1.000	252	30	326	443	18	314	337	339	0.670	0.881
LOKIASV2_0185_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A	1lew-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A	1.833E-10	1.000	252	8	306	443	5	305	341	348	0.675	0.883
LOKIASV2_0185_ESMFold_hypothetical_protein	5uoj-assembly1.cif.gz_A	5uoj-assembly1.cif.gz_A THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTROMS RESOLUTION	2.682E-10	1.000	252	8	306	443	5	308	343	347	0.675	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	3.644E-09	1.000	252	4	291	443	4	347	349	374	0.650	0.986
LOKIASV2_0185_ESMFold_hypothetical_protein	1bl6-assembly1.cif.gz_A	1bl6-assembly1.cif.gz_A THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995	1.397E-10	1.000	252	3	306	443	1	315	351	351	0.686	0.897
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly5.cif.gz_E	7qwk-assembly5.cif.gz_E GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	9.180E-09	1.000	251	16	280	443	7	226	241	277	0.598	0.913
LOKIASV2_0185_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B	6nzp-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	1.797E-09	1.000	251	16	292	443	10	259	260	299	0.625	0.962
LOKIASV2_0185_ESMFold_hypothetical_protein	6ac9-assembly4.cif.gz_D	6ac9-assembly4.cif.gz_D Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	7.799E-09	1.000	251	4	304	443	1	301	306	331	0.679	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	6cmm-assembly4.cif.gz_D	6cmm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	4.528E-09	1.000	251	4	291	443	1	298	315	323	0.650	0.946
LOKIASV2_0185_ESMFold_hypothetical_protein	3o8p-assembly1.cif.gz_A	3o8p-assembly1.cif.gz_A Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding	8.866E-10	1.000	251	8	306	443	5	303	336	347	0.675	0.890
LOKIASV2_0185_ESMFold_hypothetical_protein	2y8o-assembly1.cif.gz_A	2y8o-assembly1.cif.gz_A Crystal structure of human p38alpha complexed with a MAPK docking peptide	3.333E-10	1.000	251	8	306	443	6	304	339	347	0.675	0.882
LOKIASV2_0185_ESMFold_hypothetical_protein	6cqh-assembly3.cif.gz_C	6cqh-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	8.234E-09	1.000	250	4	304	443	3	303	308	338	0.679	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	2okr-assembly2.cif.gz_D	2okr-assembly2.cif.gz_D Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer	9.362E-10	1.000	250	8	306	443	5	302	339	347	0.675	0.879
LOKIASV2_0185_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_A	5d9h-assembly1.cif.gz_A Crystal structure of SPAK (STK39) dimer in the basal activity state	3.451E-09	1.000	249	16	302	443	11	285	290	307	0.648	0.948
LOKIASV2_0185_ESMFold_hypothetical_protein	6ac9-assembly3.cif.gz_C	6ac9-assembly3.cif.gz_C Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	2.004E-09	1.000	249	5	304	443	1	302	307	335	0.677	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	3vuh-assembly1.cif.gz_A	3vuh-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M3 in MAP kinase JNK1	6.399E-10	1.000	249	5	297	443	2	313	355	353	0.661	0.879
LOKIASV2_0185_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_A	6e9w-assembly1.cif.gz_A Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	1.965E-08	1.000	249	9	303	443	62	317	383	304	0.666	0.668
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly4.cif.gz_C	5ng3-assembly4.cif.gz_C Structure of inactive kinase RIP2K(K47R)	1.762E-08	1.000	248	9	297	443	10	271	272	312	0.652	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly2.cif.gz_B	5ng3-assembly2.cif.gz_B Structure of inactive kinase RIP2K(K47R)	8.694E-09	1.000	248	9	297	443	10	274	275	314	0.652	0.964
LOKIASV2_0185_ESMFold_hypothetical_protein	6bru-assembly2.cif.gz_B	6bru-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor	1.205E-08	1.000	248	4	304	443	1	296	301	333	0.679	0.983
LOKIASV2_0185_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B	5g6v-assembly2.cif.gz_B Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	3.451E-09	1.000	248	10	295	443	1	272	302	326	0.646	0.901
LOKIASV2_0185_ESMFold_hypothetical_protein	3psc-assembly1.cif.gz_A	3psc-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits	3.789E-11	1.000	248	6	434	443	154	581	614	493	0.968	0.697
LOKIASV2_0185_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A	4aot-assembly1.cif.gz_A Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	9.693E-09	1.000	247	16	300	443	21	275	278	305	0.643	0.917
LOKIASV2_0185_ESMFold_hypothetical_protein	6btw-assembly4.cif.gz_D	6btw-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a phenyl-pteridinone inhibitor	1.141E-08	1.000	247	4	291	443	1	290	307	321	0.650	0.945
LOKIASV2_0185_ESMFold_hypothetical_protein	6bru-assembly4.cif.gz_D	6bru-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor	1.141E-08	1.000	247	3	304	443	1	306	311	337	0.682	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A	3zsi-assembly1.cif.gz_A X-ray structure of p38alpha bound to VX-745	1.527E-09	1.000	247	8	306	443	4	292	326	344	0.675	0.887
LOKIASV2_0185_ESMFold_hypothetical_protein	6sou-assembly1.cif.gz_A	6sou-assembly1.cif.gz_A Fragment N13565a in complex with MAP kinase p38-alpha	1.644E-10	1.000	247	8	310	443	5	319	342	357	0.684	0.921
LOKIASV2_0185_ESMFold_hypothetical_protein	3byv-assembly1.cif.gz_A	3byv-assembly1.cif.gz_A Crystal structure of Toxoplasma gondii specific rhoptry antigen kinase domain	3.095E-09	1.000	246	2	297	443	36	340	345	336	0.668	0.884
LOKIASV2_0185_ESMFold_hypothetical_protein	5r9q-assembly1.cif.gz_A	5r9q-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N07422b in complex with MAP kinase p38-alpha	3.157E-10	1.000	246	8	310	443	5	323	346	356	0.684	0.922
LOKIASV2_0185_ESMFold_hypothetical_protein	4lv8-assembly2.cif.gz_A	4lv8-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5C, a pseudokinase GDI	2.776E-09	1.000	246	4	297	443	42	357	360	344	0.664	0.878
LOKIASV2_0185_ESMFold_hypothetical_protein	7dts-assembly1.cif.gz_b	7dts-assembly1.cif.gz_b Crystal structure of RNase L in complex with AC40357	8.694E-09	1.000	246	9	295	443	324	549	680	296	0.648	0.332
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly3.cif.gz_A	5ng3-assembly3.cif.gz_A Structure of inactive kinase RIP2K(K47R)	2.191E-08	1.000	245	20	297	443	15	283	284	304	0.628	0.947
LOKIASV2_0185_ESMFold_hypothetical_protein	6vxu-assembly3.cif.gz_C	6vxu-assembly3.cif.gz_C Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471	1.272E-08	1.000	245	4	304	443	3	306	311	338	0.679	0.977
LOKIASV2_0185_ESMFold_hypothetical_protein	6cfm-assembly4.cif.gz_D	6cfm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a propynyl-pteridinone inhibitor	6.995E-09	1.000	245	3	304	443	1	308	313	343	0.682	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_C	4w7p-assembly3.cif.gz_C Crystal Structure of ROCK 1 bound to YB-15-QD37	2.313E-08	1.000	245	9	303	443	65	318	383	307	0.666	0.663
LOKIASV2_0185_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B	5bml-assembly1.cif.gz_B ROCK 1 bound to a pyridine thiazole inhibitor	3.847E-09	1.000	245	9	307	443	66	330	395	317	0.675	0.671
LOKIASV2_0185_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	3.095E-09	1.000	245	9	298	443	113	377	411	300	0.655	0.645
LOKIASV2_0185_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A	5r96-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP kinase p38-alpha	3.157E-10	1.000	244	8	306	443	5	313	347	347	0.675	0.890
LOKIASV2_0185_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B	6o8b-assembly1.cif.gz_B Crystal structure of STING CTD in complex with TBK1	1.557E-10	1.000	244	7	329	443	2	366	657	405	0.729	0.556
LOKIASV2_0185_ESMFold_hypothetical_protein	8q1z-assembly1.cif.gz_A	8q1z-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to JA-296	1.272E-08	1.000	243	4	292	443	1	295	311	323	0.652	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_A	4nif-assembly1.cif.gz_A Heterodimeric structure of ERK2 and RSK1	3.451E-09	1.000	243	16	300	443	6	264	313	305	0.643	0.827
LOKIASV2_0185_ESMFold_hypothetical_protein	5n65-assembly1.cif.gz_A	5n65-assembly1.cif.gz_A Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9h	1.229E-09	1.000	243	8	306	443	5	299	333	348	0.675	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	6m11-assembly1.cif.gz_b	6m11-assembly1.cif.gz_b Crystal structure of Rnase L in complex with Sunitinib	1.762E-08	1.000	243	16	279	443	334	549	684	273	0.596	0.316
LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_A	3dak-assembly2.cif.gz_A Crystal Structure of Domain-Swapped OSR1 kinase domain	3.644E-09	1.000	242	16	292	443	12	276	279	301	0.625	0.950
LOKIASV2_0185_ESMFold_hypothetical_protein	3ocg-assembly1.cif.gz_A	3ocg-assembly1.cif.gz_A P38 Alpha kinase complexed with a 5-amino-pyrazole based inhibitor	1.446E-09	1.000	242	8	306	443	6	302	336	347	0.675	0.884
LOKIASV2_0185_ESMFold_hypothetical_protein	3hv5-assembly1.cif.gz_A	3hv5-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL24	7.953E-10	1.000	242	8	306	443	6	305	339	348	0.675	0.885
LOKIASV2_0185_ESMFold_hypothetical_protein	5r90-assembly1.cif.gz_A	5r90-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11145a in complex with MAP kinase p38-alpha	3.519E-10	1.000	242	3	306	443	1	308	342	353	0.686	0.901
LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	1.023E-08	1.000	242	4	291	443	4	350	352	380	0.650	0.986
LOKIASV2_0185_ESMFold_hypothetical_protein	5he1-assembly1.cif.gz_A	5he1-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224062	4.973E-11	1.000	242	6	440	443	154	591	618	509	0.982	0.709
LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly4.cif.gz_D	3op5-assembly4.cif.gz_D Human vaccinia-related kinase 1	1.497E-08	1.000	241	7	304	443	2	297	302	327	0.673	0.980
LOKIASV2_0185_ESMFold_hypothetical_protein	1zz2-assembly1.cif.gz_A	1zz2-assembly1.cif.gz_A Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes	1.702E-09	1.000	241	8	306	443	5	303	337	348	0.675	0.887
LOKIASV2_0185_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A	3uvq-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative	3.095E-09	1.000	240	8	294	443	5	291	333	337	0.648	0.862
LOKIASV2_0185_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	1.527E-09	1.000	240	3	295	443	1	291	336	342	0.661	0.866
LOKIASV2_0185_ESMFold_hypothetical_protein	8bzp-assembly1.cif.gz_A	8bzp-assembly1.cif.gz_A JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	1.797E-09	1.000	240	5	297	443	1	310	350	351	0.661	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	5he3-assembly1.cif.gz_A	5he3-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224411	2.590E-11	1.000	240	6	437	443	153	587	623	499	0.975	0.698
LOKIASV2_0185_ESMFold_hypothetical_protein	8wf4-assembly2.cif.gz_B	8wf4-assembly2.cif.gz_B The Crystal Structure of RSK1 from Biortus.	6.625E-09	1.000	239	16	300	443	4	261	290	303	0.643	0.890
LOKIASV2_0185_ESMFold_hypothetical_protein	6cnx-assembly4.cif.gz_D	6cnx-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor	2.075E-08	1.000	239	5	304	443	1	307	312	338	0.677	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	1ian-assembly1.cif.gz_A	1ian-assembly1.cif.gz_A HUMAN P38 MAP KINASE INHIBITOR COMPLEX	1.898E-09	1.000	239	5	306	443	1	294	328	352	0.682	0.896
LOKIASV2_0185_ESMFold_hypothetical_protein	7z9t-assembly1.cif.gz_AAA	7z9t-assembly1.cif.gz_AAA Crystal structure of p38alpha C162S in complex with ATPgS and CAS 2094667-81-7 (in catalytic site, Y35 out), P 1 21 1	4.618E-10	1.000	239	8	306	443	5	314	349	350	0.675	0.888
LOKIASV2_0185_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A	3i6u-assembly1.cif.gz_A Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	6.275E-09	1.000	239	13	298	443	130	390	390	312	0.646	0.669
LOKIASV2_0185_ESMFold_hypothetical_protein	4pnk-assembly1.cif.gz_A	4pnk-assembly1.cif.gz_A G protein-coupled receptor kinase 2 in complex with GSK180736A	7.682E-11	1.000	239	7	432	443	154	590	625	494	0.962	0.699
LOKIASV2_0185_ESMFold_hypothetical_protein	6u7c-assembly1.cif.gz_A	6u7c-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258747	4.973E-11	1.000	239	6	431	443	153	593	631	493	0.962	0.699
LOKIASV2_0185_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A	7wj7-assembly1.cif.gz_A Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	5.943E-09	1.000	238	16	306	443	3	242	242	306	0.657	0.992
LOKIASV2_0185_ESMFold_hypothetical_protein	3e3p-assembly1.cif.gz_A	3e3p-assembly1.cif.gz_A Glycogen synthase kinase from Leishmania major	1.205E-08	1.000	238	31	293	443	19	299	337	309	0.594	0.834
LOKIASV2_0185_ESMFold_hypothetical_protein	7mt9-assembly1.cif.gz_G	7mt9-assembly1.cif.gz_G Rhodopsin kinase (GRK1) in complex with rhodopsin	2.490E-09	1.000	238	16	366	443	25	346	346	372	0.792	0.931
LOKIASV2_0185_ESMFold_hypothetical_protein	5ekn-assembly1.cif.gz_A	5ekn-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	9.885E-10	1.000	237	5	297	443	5	294	336	343	0.661	0.863
LOKIASV2_0185_ESMFold_hypothetical_protein	6hwv-assembly1.cif.gz_A	6hwv-assembly1.cif.gz_A Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (compound 3)	2.490E-09	1.000	237	8	306	443	5	302	336	348	0.675	0.887
LOKIASV2_0185_ESMFold_hypothetical_protein	3fsk-assembly1.cif.gz_A	3fsk-assembly1.cif.gz_A P38 kinase crystal structure in complex with RO6257	9.885E-10	1.000	237	8	306	443	5	308	342	350	0.675	0.889
LOKIASV2_0185_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2	6e9w-assembly1.cif.gz_B-2 Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	1.023E-08	1.000	237	9	305	443	64	340	380	320	0.670	0.729
LOKIASV2_0185_ESMFold_hypothetical_protein	3uzs-assembly1.cif.gz_A	3uzs-assembly1.cif.gz_A Structure of the C13.28 RNA Aptamer Bound to the G Protein-Coupled Receptor Kinase 2-Heterotrimeric G Protein Beta 1 and Gamma 2 Subunit Complex	2.590E-11	1.000	237	6	435	443	154	574	609	493	0.971	0.691
LOKIASV2_0185_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A	7wj6-assembly1.cif.gz_A Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	6.995E-09	1.000	236	16	293	443	3	242	244	296	0.628	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B	5dbx-assembly1.cif.gz_B Crystal structure of murine SPAK(T243D) in complex with AMPPNP	7.386E-09	1.000	236	16	307	443	10	281	282	313	0.659	0.965
LOKIASV2_0185_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A	2ghl-assembly1.cif.gz_A Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743	2.359E-09	1.000	236	8	306	443	5	300	334	347	0.675	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	3lhj-assembly1.cif.gz_A	3lhj-assembly1.cif.gz_A Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inhibitor.	1.702E-09	1.000	236	8	306	443	5	307	341	354	0.675	0.889
LOKIASV2_0185_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B	5wng-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	9.180E-09	1.000	236	9	307	443	66	307	365	300	0.675	0.663
LOKIASV2_0185_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A	6hhf-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib	3.772E-08	1.000	236	10	298	443	104	337	366	297	0.652	0.639
LOKIASV2_0185_ESMFold_hypothetical_protein	8gds-assembly2.cif.gz_B	8gds-assembly2.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	1.343E-08	1.000	236	10	290	443	64	322	384	304	0.634	0.674
LOKIASV2_0185_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B	5wvd-assembly1.cif.gz_B Structure of Mnk1 in complex with DS12881479	9.002E-08	1.000	235	16	289	443	8	208	212	291	0.619	0.948
LOKIASV2_0185_ESMFold_hypothetical_protein	8p4z-assembly2.cif.gz_B	8p4z-assembly2.cif.gz_B Crystal structure of the human CDK7 kinase domain in complex with LDC4297	3.772E-08	1.000	235	16	301	443	4	268	278	319	0.646	0.953
LOKIASV2_0185_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B	7kac-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	2.630E-09	1.000	235	13	300	443	9	276	288	317	0.650	0.931
LOKIASV2_0185_ESMFold_hypothetical_protein	5o90-assembly1.cif.gz_A	5o90-assembly1.cif.gz_A Crystal structure of a P38alpha T185G mutant in complex with TAB1 peptide.	3.451E-09	1.000	235	8	306	443	5	295	330	338	0.675	0.882
LOKIASV2_0185_ESMFold_hypothetical_protein	4h39-assembly1.cif.gz_A	4h39-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with JIP1 Peptide	3.644E-09	1.000	235	8	297	443	5	300	340	340	0.655	0.871
LOKIASV2_0185_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B	2w1z-assembly2.cif.gz_B ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	1.861E-08	1.000	235	9	302	443	48	351	358	329	0.664	0.849
LOKIASV2_0185_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	4.062E-09	1.000	234	1	298	443	9	276	279	309	0.673	0.961
LOKIASV2_0185_ESMFold_hypothetical_protein	5r9w-assembly1.cif.gz_A	5r9w-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13598a in complex with MAP kinase p38-alpha	6.399E-10	1.000	234	8	305	443	5	322	348	353	0.673	0.914
LOKIASV2_0185_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A	3hdm-assembly1.cif.gz_A Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 1	5.628E-09	1.000	232	2	300	443	1	268	285	326	0.675	0.940
LOKIASV2_0185_ESMFold_hypothetical_protein	6bp0-assembly2.cif.gz_B	6bp0-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase 1 bound to (R)-2-phenylaminopteridinone inhibitor	4.441E-08	1.000	232	4	304	443	1	299	304	334	0.679	0.984
LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_C	7s26-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G5018	6.859E-08	1.000	232	9	291	443	63	311	363	303	0.639	0.686
LOKIASV2_0185_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2	6cqf-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex an inhibitor G1858	2.579E-08	1.000	231	13	298	443	10	265	282	300	0.646	0.908
LOKIASV2_0185_ESMFold_hypothetical_protein	6dd4-assembly2.cif.gz_B	6dd4-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	5.943E-09	1.000	231	4	300	443	1	290	309	320	0.670	0.939
LOKIASV2_0185_ESMFold_hypothetical_protein	3uvr-assembly1.cif.gz_A	3uvr-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with KM064	2.359E-09	1.000	231	8	306	443	5	298	331	343	0.675	0.888
LOKIASV2_0185_ESMFold_hypothetical_protein	8aco-assembly1.cif.gz_AAA	8aco-assembly1.cif.gz_AAA Crystal structure of WT p38alpha	2.359E-09	1.000	231	8	306	443	6	300	334	347	0.675	0.883
LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	3.772E-08	1.000	231	4	291	443	4	349	351	379	0.650	0.986
LOKIASV2_0185_ESMFold_hypothetical_protein	5yt3-assembly2.cif.gz_D	5yt3-assembly2.cif.gz_D Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 S218D and S222D mutant	3.268E-09	1.000	230	10	300	443	25	292	309	308	0.657	0.867
LOKIASV2_0185_ESMFold_hypothetical_protein	2v62-assembly2.cif.gz_B	2v62-assembly2.cif.gz_B Structure of vaccinia-related kinase 2	4.206E-08	1.000	230	4	292	443	1	294	310	322	0.652	0.948
LOKIASV2_0185_ESMFold_hypothetical_protein	6ycu-assembly1.cif.gz_A	6ycu-assembly1.cif.gz_A Fragment KCL_K777 in complex with MAP kinase p38-alpha	4.781E-09	1.000	230	8	306	443	4	306	347	349	0.675	0.873
LOKIASV2_0185_ESMFold_hypothetical_protein	7dsy-assembly1.cif.gz_b	7dsy-assembly1.cif.gz_b Crystal Structure of RNase L in complex with KM05073	4.441E-08	1.000	230	9	295	443	320	545	676	292	0.648	0.334
LOKIASV2_0185_ESMFold_hypothetical_protein	5uvf-assembly3.cif.gz_C	5uvf-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to BI-D1870	6.995E-09	1.000	229	7	296	443	4	268	301	299	0.655	0.880
LOKIASV2_0185_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A	8x5l-assembly1.cif.gz_A The Crystal Structure of PRKACA from Biortus.	1.081E-08	1.000	229	10	296	443	23	288	331	318	0.648	0.804
LOKIASV2_0185_ESMFold_hypothetical_protein	3gcp-assembly1.cif.gz_A	3gcp-assembly1.cif.gz_A Human P38 MAP Kinase in Complex with SB203580	4.781E-09	1.000	229	8	306	443	6	303	337	347	0.675	0.884
LOKIASV2_0185_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A	7pvu-assembly1.cif.gz_A Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	1.797E-09	1.000	229	8	306	443	5	302	337	347	0.675	0.884
LOKIASV2_0185_ESMFold_hypothetical_protein	6anl-assembly1.cif.gz_A	6anl-assembly1.cif.gz_A Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 MAP Kinase Inhibitors	2.776E-09	1.000	229	8	306	443	6	304	338	347	0.675	0.885
LOKIASV2_0185_ESMFold_hypothetical_protein	3bv3-assembly1.cif.gz_A	3bv3-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha Map Kinase inhibitor compound 2	6.275E-09	1.000	229	16	304	443	20	311	338	335	0.652	0.864
LOKIASV2_0185_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B	7wj7-assembly1.cif.gz_B Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	1.141E-08	1.000	228	16	291	443	4	243	246	293	0.623	0.976
LOKIASV2_0185_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	9.693E-09	1.000	228	13	298	443	11	268	284	312	0.646	0.908
LOKIASV2_0185_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A	1kv1-assembly1.cif.gz_A p38 MAP Kinase in Complex with Inhibitor 1	3.644E-09	1.000	228	5	306	443	1	297	331	351	0.682	0.897
LOKIASV2_0185_ESMFold_hypothetical_protein	3bv2-assembly1.cif.gz_A	3bv2-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30	2.776E-09	1.000	228	8	306	443	5	304	337	348	0.675	0.890
LOKIASV2_0185_ESMFold_hypothetical_protein	5etf-assembly1.cif.gz_A	5etf-assembly1.cif.gz_A Structure of dead kinase MAPK14 with bound the KIM domain of MKK6	3.644E-09	1.000	228	8	306	443	6	303	338	350	0.675	0.882
LOKIASV2_0185_ESMFold_hypothetical_protein	7elw-assembly1.cif.gz_b	7elw-assembly1.cif.gz_b Crystal structure of RNase L in complex with Myricetin	3.983E-08	1.000	228	9	277	443	320	533	676	283	0.607	0.317
LOKIASV2_0185_ESMFold_hypothetical_protein	7mfd-assembly1.cif.gz_B	7mfd-assembly1.cif.gz_B Autoinhibited BRAF:(14-3-3)2:MEK complex with the BRAF RBD resolved	1.669E-08	1.000	227	1	300	443	3	275	293	315	0.677	0.932
LOKIASV2_0185_ESMFold_hypothetical_protein	3q5z-assembly1.cif.gz_A	3q5z-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain	3.772E-08	1.000	227	4	300	443	42	334	336	328	0.670	0.872
LOKIASV2_0185_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	3.772E-08	1.000	227	3	298	443	1	348	348	380	0.668	1.000
LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B	7s26-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G5018	4.951E-08	1.000	227	9	291	443	65	312	372	306	0.639	0.667
LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B	4w7p-assembly3.cif.gz_B Crystal Structure of ROCK 1 bound to YB-15-QD37	4.441E-08	1.000	227	9	307	443	65	323	387	316	0.675	0.669
LOKIASV2_0185_ESMFold_hypothetical_protein	4e5a-assembly1.cif.gz_X	4e5a-assembly1.cif.gz_X The W197A mutant of p38a MAP kinase	2.359E-09	1.000	226	3	306	443	1	297	332	354	0.686	0.895
LOKIASV2_0185_ESMFold_hypothetical_protein	3huc-assembly1.cif.gz_A	3huc-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL40	3.268E-09	1.000	226	3	306	443	1	303	337	354	0.686	0.899
LOKIASV2_0185_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A	1ywr-assembly1.cif.gz_A Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor	2.932E-09	1.000	226	8	306	443	5	304	338	351	0.675	0.888
LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B	7s25-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G4998	3.205E-08	1.000	226	9	280	443	63	304	379	292	0.614	0.639
LOKIASV2_0185_ESMFold_hypothetical_protein	4hys-assembly1.cif.gz_A	4hys-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan	8.234E-09	1.000	225	5	297	443	1	292	321	343	0.661	0.910
LOKIASV2_0185_ESMFold_hypothetical_protein	6so2-assembly1.cif.gz_A	6so2-assembly1.cif.gz_A Fragment N13460a in complex with MAP kinase p38-alpha	1.797E-09	1.000	225	3	306	443	1	311	345	354	0.686	0.901
LOKIASV2_0185_ESMFold_hypothetical_protein	6y7y-assembly1.cif.gz_A	6y7y-assembly1.cif.gz_A Fragments KCL_771 and KCL_802 in complex with MAP kinase p38-alpha	1.081E-08	1.000	224	8	306	443	4	302	343	348	0.675	0.872
LOKIASV2_0185_ESMFold_hypothetical_protein	6sp9-assembly1.cif.gz_A	6sp9-assembly1.cif.gz_A Fragment KCL802 in complex with MAP kinase p38-alpha	1.669E-08	1.000	224	8	306	443	5	307	348	349	0.675	0.871
LOKIASV2_0185_ESMFold_hypothetical_protein	4o2z-assembly1.cif.gz_A-2	4o2z-assembly1.cif.gz_A-2 Crystal Structure of MPK3 from Leishmania donovani, LdBPK_100540 in the presence of NVP-BBT594	5.628E-09	1.000	224	16	307	443	35	345	363	344	0.659	0.857
LOKIASV2_0185_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A	7m74-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	1.164E-09	1.000	224	10	437	443	1	351	380	441	0.966	0.924
LOKIASV2_0185_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C	7l24-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 11	9.693E-09	1.000	223	16	301	443	10	283	283	324	0.646	0.968
LOKIASV2_0185_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A	2gtn-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717	7.386E-09	1.000	223	8	306	443	5	303	337	349	0.675	0.887
LOKIASV2_0185_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A	3q60-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain bound to ATP	3.983E-08	1.000	223	14	300	443	57	346	350	314	0.648	0.829
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly2.cif.gz_C	4o1p-assembly2.cif.gz_C Crystal Structure of RNase L in complex with 2-5A and AMP-PNP	1.927E-07	1.000	223	9	277	443	322	538	673	277	0.607	0.322
LOKIASV2_0185_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B	7wj6-assembly1.cif.gz_B Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	3.384E-08	1.000	222	16	293	443	5	239	241	293	0.628	0.975
LOKIASV2_0185_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A	6sov-assembly1.cif.gz_A Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alpha	2.075E-08	1.000	222	8	306	443	4	304	345	348	0.675	0.872
LOKIASV2_0185_ESMFold_hypothetical_protein	5r94-assembly1.cif.gz_A	5r94-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL081 in complex with MAP kinase p38-alpha	2.630E-09	1.000	222	8	306	443	6	312	346	348	0.675	0.887
LOKIASV2_0185_ESMFold_hypothetical_protein	6y80-assembly1.cif.gz_A	6y80-assembly1.cif.gz_A Fragment KCL_916 in complex with MAP kinase p38-alpha	1.418E-08	1.000	222	8	306	443	5	306	347	349	0.675	0.870
LOKIASV2_0185_ESMFold_hypothetical_protein	6hhh-assembly1.cif.gz_A	6hhh-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31	5.519E-08	1.000	222	10	298	443	110	350	379	296	0.652	0.636
LOKIASV2_0185_ESMFold_hypothetical_protein	4aa5-assembly1.cif.gz_A	4aa5-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 33	9.180E-09	1.000	221	8	306	443	5	306	340	347	0.675	0.888
LOKIASV2_0185_ESMFold_hypothetical_protein	3dzo-assembly1.cif.gz_A	3dzo-assembly1.cif.gz_A Crystal structure of a rhoptry kinase from toxoplasma gondii	4.951E-08	1.000	221	5	300	443	47	345	348	335	0.668	0.859
LOKIASV2_0185_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A	4izy-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan	1.205E-08	1.000	220	5	297	443	1	293	322	344	0.661	0.910
LOKIASV2_0185_ESMFold_hypothetical_protein	6y7w-assembly1.cif.gz_A	6y7w-assembly1.cif.gz_A Fragment KCL_1337 in complex with MAP kinase p38-alpha	1.861E-08	1.000	220	8	306	443	4	303	344	348	0.675	0.872
LOKIASV2_0185_ESMFold_hypothetical_protein	6m13-assembly1.cif.gz_a	6m13-assembly1.cif.gz_a Crystal structure of Rnase L in complex with Toceranib	2.723E-08	1.000	220	9	305	443	328	552	681	306	0.670	0.330
LOKIASV2_0185_ESMFold_hypothetical_protein	8acm-assembly1.cif.gz_AAA	8acm-assembly1.cif.gz_AAA Crystal structure of WT p38alpha	9.693E-09	1.000	219	8	306	443	6	302	337	349	0.675	0.881
LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C	7s25-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G4998	2.579E-08	1.000	219	9	307	443	58	304	361	317	0.675	0.684
LOKIASV2_0185_ESMFold_hypothetical_protein	3k3i-assembly1.cif.gz_A	3k3i-assembly1.cif.gz_A p38alpha bound to novel DGF-out compound PF-00215955	1.023E-08	1.000	218	8	306	443	5	298	332	347	0.675	0.886
LOKIASV2_0185_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A	7siu-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	1.581E-08	1.000	217	16	298	443	18	277	295	307	0.639	0.881
LOKIASV2_0185_ESMFold_hypothetical_protein	5xzw-assembly3.cif.gz_A	5xzw-assembly3.cif.gz_A Crystal structure of Rad53 1-466	3.699E-07	1.000	216	16	288	443	146	374	378	283	0.616	0.606
LOKIASV2_0185_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A	2w1z-assembly1.cif.gz_A ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	3.573E-08	1.000	215	14	302	443	58	348	354	324	0.652	0.822
LOKIASV2_0185_ESMFold_hypothetical_protein	7dts-assembly1.cif.gz_a	7dts-assembly1.cif.gz_a Crystal structure of RNase L in complex with AC40357	1.205E-08	1.000	215	1	305	443	319	542	672	309	0.688	0.333
LOKIASV2_0185_ESMFold_hypothetical_protein	6m11-assembly1.cif.gz_a	6m11-assembly1.cif.gz_a Crystal structure of Rnase L in complex with Sunitinib	2.875E-08	1.000	215	9	305	443	330	551	681	301	0.670	0.326
LOKIASV2_0185_ESMFold_hypothetical_protein	6m13-assembly1.cif.gz_b	6m13-assembly1.cif.gz_b Crystal structure of Rnase L in complex with Toceranib	4.689E-08	1.000	215	8	298	443	329	544	688	295	0.657	0.314
LOKIASV2_0185_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A	7l24-assembly1.cif.gz_A HPK1 IN COMPLEX WITH COMPOUND 11	3.205E-08	1.000	214	16	300	443	11	272	283	314	0.643	0.926
LOKIASV2_0185_ESMFold_hypothetical_protein	6npn-assembly2.cif.gz_B	6npn-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine-3-hydroxyindazole inhibitor	1.927E-07	1.000	214	5	304	443	1	296	301	331	0.677	0.983
LOKIASV2_0185_ESMFold_hypothetical_protein	4lv5-assembly2.cif.gz_A	4lv5-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5B, a pseudokinase GDI	3.772E-08	1.000	214	14	295	443	58	349	350	325	0.637	0.834
LOKIASV2_0185_ESMFold_hypothetical_protein	3new-assembly1.cif.gz_A	3new-assembly1.cif.gz_A p38-alpha complexed with Compound 10	2.442E-08	1.000	213	8	303	443	5	297	334	348	0.668	0.877
LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_D	4w7p-assembly3.cif.gz_D Crystal Structure of ROCK 1 bound to YB-15-QD37	1.581E-08	1.000	213	9	307	443	65	323	387	311	0.675	0.669
LOKIASV2_0185_ESMFold_hypothetical_protein	4l8m-assembly1.cif.gz_A	4l8m-assembly1.cif.gz_A Human p38 MAP kinase in complex with a Dibenzoxepinone	5.827E-08	1.000	212	8	306	443	5	305	339	347	0.675	0.888
LOKIASV2_0185_ESMFold_hypothetical_protein	4aa0-assembly1.cif.gz_A	4aa0-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 2	1.023E-08	1.000	211	8	310	443	5	306	328	358	0.684	0.921
LOKIASV2_0185_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A	7kac-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	1.965E-08	1.000	210	13	306	443	9	273	283	325	0.664	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_B	7siu-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	3.035E-08	1.000	210	16	307	443	7	283	284	316	0.659	0.975
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukl-assembly1.cif.gz_A	5ukl-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG222886 (14bd)	6.399E-10	1.000	210	6	442	443	152	600	630	509	0.986	0.713
LOKIASV2_0185_ESMFold_hypothetical_protein	7elw-assembly1.cif.gz_a	7elw-assembly1.cif.gz_a Crystal structure of RNase L in complex with Myricetin	4.441E-08	1.000	210	16	305	443	330	545	675	294	0.655	0.320
LOKIASV2_0185_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A	6s9x-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c	1.637E-07	1.000	209	8	298	443	105	349	382	301	0.657	0.641
LOKIASV2_0185_ESMFold_hypothetical_protein	6m12-assembly1.cif.gz_a	6m12-assembly1.cif.gz_a Crystal Structure of Rnase L in complex with SU11652	3.983E-08	1.000	209	16	305	443	332	550	681	297	0.655	0.322
LOKIASV2_0185_ESMFold_hypothetical_protein	5uvf-assembly4.cif.gz_D	5uvf-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to BI-D1870	3.318E-07	1.000	208	7	304	443	2	291	296	326	0.673	0.980
LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A	7s25-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G4998	4.354E-07	1.000	208	9	303	443	64	302	373	305	0.666	0.641
LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_A	4w7p-assembly3.cif.gz_A Crystal Structure of ROCK 1 bound to YB-15-QD37	3.205E-08	1.000	208	9	307	443	65	323	388	311	0.675	0.668
LOKIASV2_0185_ESMFold_hypothetical_protein	7byk-assembly1.cif.gz_A	7byk-assembly1.cif.gz_A Crystal structure of the Legionella pneumophila LegK7 effector kinase	6.153E-08	1.000	208	30	292	443	173	430	448	291	0.594	0.576
LOKIASV2_0185_ESMFold_hypothetical_protein	6m12-assembly1.cif.gz_b	6m12-assembly1.cif.gz_b Crystal Structure of Rnase L in complex with SU11652	5.519E-08	1.000	208	16	298	443	335	543	684	289	0.639	0.306
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly1.cif.gz_B	4o1p-assembly1.cif.gz_B Crystal Structure of RNase L in complex with 2-5A and AMP-PNP	1.181E-07	1.000	206	9	305	443	322	543	671	303	0.670	0.331
LOKIASV2_0185_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	1.695E-06	1.000	205	1	306	443	4	270	270	325	0.691	0.989
LOKIASV2_0185_ESMFold_hypothetical_protein	4oth-assembly1.cif.gz_A	4oth-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Ro-31-8220	2.395E-07	1.000	205	8	297	443	3	251	306	314	0.655	0.814
LOKIASV2_0185_ESMFold_hypothetical_protein	4e8a-assembly1.cif.gz_A	4e8a-assembly1.cif.gz_A The crystal structure of p38a MAP kinase in complex with PIA24	1.861E-08	1.000	205	3	295	443	1	283	327	340	0.661	0.865
LOKIASV2_0185_ESMFold_hypothetical_protein	2bak-assembly1.cif.gz_A	2bak-assembly1.cif.gz_A p38alpha MAP kinase bound to MPAQ	2.075E-08	1.000	205	8	306	443	5	299	334	348	0.675	0.883
LOKIASV2_0185_ESMFold_hypothetical_protein	4oti-assembly1.cif.gz_A	4oti-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Tofacitinib	3.143E-07	1.000	204	8	297	443	3	249	304	311	0.655	0.812
LOKIASV2_0185_ESMFold_hypothetical_protein	2v62-assembly1.cif.gz_A	2v62-assembly1.cif.gz_A Structure of vaccinia-related kinase 2	3.143E-07	1.000	203	4	292	443	1	293	309	323	0.652	0.948
LOKIASV2_0185_ESMFold_hypothetical_protein	1yw2-assembly1.cif.gz_A	1yw2-assembly1.cif.gz_A Mutated Mus Musculus P38 Kinase (mP38)	5.827E-08	1.000	203	3	306	443	1	306	341	352	0.686	0.897
LOKIASV2_0185_ESMFold_hypothetical_protein	1kv2-assembly1.cif.gz_A	1kv2-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with BIRB 796	3.035E-08	1.000	201	5	306	443	1	291	325	357	0.682	0.895
LOKIASV2_0185_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A	8cdw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	9.002E-08	1.000	199	16	300	443	11	273	285	311	0.643	0.923
LOKIASV2_0185_ESMFold_hypothetical_protein	2baj-assembly1.cif.gz_A	2baj-assembly1.cif.gz_A p38alpha bound to pyrazolourea	2.579E-08	1.000	199	16	300	443	23	299	337	327	0.643	0.822
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly2.cif.gz_D	4o1p-assembly2.cif.gz_D Crystal Structure of RNase L in complex with 2-5A and AMP-PNP	2.528E-07	1.000	199	9	302	443	322	541	668	301	0.664	0.329
LOKIASV2_0185_ESMFold_hypothetical_protein	4awi-assembly1.cif.gz_A	4awi-assembly1.cif.gz_A Human Jnk1alpha kinase with 4-phenyl-7-azaindole IKK2 inhibitor.	1.141E-08	1.000	197	5	297	443	1	350	352	384	0.661	0.994
LOKIASV2_0185_ESMFold_hypothetical_protein	7byk-assembly2.cif.gz_B	7byk-assembly2.cif.gz_B Crystal structure of the Legionella pneumophila LegK7 effector kinase	1.468E-07	1.000	197	40	300	443	187	448	452	295	0.589	0.580
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1o-assembly1.cif.gz_A	4o1o-assembly1.cif.gz_A Crystal Structure of RNase L in complex with 2-5A	2.528E-07	1.000	197	9	305	443	321	541	672	301	0.670	0.329
LOKIASV2_0185_ESMFold_hypothetical_protein	4kin-assembly1.cif.gz_A	4kin-assembly1.cif.gz_A Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE	8.525E-08	1.000	194	8	295	443	5	293	338	338	0.650	0.855
LOKIASV2_0185_ESMFold_hypothetical_protein	6cfm-assembly2.cif.gz_B	6cfm-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a propynyl-pteridinone inhibitor	1.550E-07	1.000	191	4	300	443	1	278	297	319	0.670	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1o-assembly2.cif.gz_C	4o1o-assembly2.cif.gz_C Crystal Structure of RNase L in complex with 2-5A	4.854E-07	1.000	189	16	302	443	326	540	671	293	0.648	0.320
LOKIASV2_0185_ESMFold_hypothetical_protein	3alo-assembly1.cif.gz_A	3alo-assembly1.cif.gz_A Crystal structure of human non-phosphorylated MKK4 kinase domain ternary complex with AMP-PNP and p38 peptide	3.906E-07	1.000	184	16	306	443	8	289	289	322	0.657	0.976
LOKIASV2_0185_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	1.158E-06	1.000	179	16	287	443	7	211	277	275	0.614	0.740
LOKIASV2_0185_ESMFold_hypothetical_protein	3oht-assembly1.cif.gz_B	3oht-assembly1.cif.gz_B Crystal Structure of Salmo Salar p38alpha	1.247E-07	1.000	177	8	304	443	6	297	331	351	0.670	0.882
LOKIASV2_0185_ESMFold_hypothetical_protein	6dfl-assembly1.cif.gz_A	6dfl-assembly1.cif.gz_A WaaP in complex with acyl carrier protein	4.598E-07	1.000	169	20	300	443	28	237	241	286	0.634	0.871
LOKIASV2_0185_ESMFold_hypothetical_protein	4jon-assembly3.cif.gz_C	4jon-assembly3.cif.gz_C Crystal structure of a centrosomal protein 170kDa, transcript variant beta (CEP170) from Homo sapiens at 2.15 A resolution (PSI Community Target, Sundstrom)	2.658E-04	1.000	156	312	443	443	4	112	118	138	0.298	0.924
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly2.cif.gz_B	5ukf-assembly2.cif.gz_B Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	6.247E-06	1.000	155	56	304	443	13	260	265	277	0.562	0.936
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly4.cif.gz_D	5ukf-assembly4.cif.gz_D Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	3.369E-05	1.000	148	46	304	443	6	263	268	288	0.585	0.963
LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D	7s25-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G4998	2.963E-04	1.000	138	9	168	443	62	200	257	161	0.361	0.541
LOKIASV2_0185_ESMFold_hypothetical_protein	6hc1-assembly2.cif.gz_B	6hc1-assembly2.cif.gz_B Bdellovibrio bacteriovorus DgcB FHA in complex with phosphorylated N-terminal peptide	4.739E-03	1.000	129	313	434	443	2	99	102	127	0.275	0.961
LOKIASV2_0185_ESMFold_hypothetical_protein	3els-assembly1.cif.gz_A	3els-assembly1.cif.gz_A Crystal Structure of Yeast Pml1p, Residues 51-204	8.787E-04	1.000	127	302	436	443	15	145	145	153	0.305	0.903
LOKIASV2_0185_ESMFold_hypothetical_protein	2csw-assembly1.cif.gz_A	2csw-assembly1.cif.gz_A Solution structure of the FHA domain of human ubiquitin ligase protein RNF8	1.153E-03	1.000	123	311	442	443	15	133	145	149	0.298	0.821
LOKIASV2_0185_ESMFold_hypothetical_protein	4h87-assembly2.cif.gz_A	4h87-assembly2.cif.gz_A Crystal structure of a FHA domain of kanadaptin (SLC4A1AP) from Homo sapiens at 1.55 A resolution	3.239E-03	1.000	115	310	434	443	17	123	124	131	0.282	0.863
LOKIASV2_0185_ESMFold_hypothetical_protein	3elv-assembly2.cif.gz_B	3elv-assembly2.cif.gz_B Crystal Structure of Full-Length Yeast Pml1p	3.239E-03	1.000	114	302	436	443	15	144	144	153	0.305	0.903
LOKIASV2_0185_ESMFold_hypothetical_protein	4h87-assembly3.cif.gz_B	4h87-assembly3.cif.gz_B Crystal structure of a FHA domain of kanadaptin (SLC4A1AP) from Homo sapiens at 1.55 A resolution	3.420E-03	1.000	112	310	434	443	17	122	123	132	0.282	0.862
LOKIASV2_0185_ESMFold_hypothetical_protein	3vpy-assembly1.cif.gz_A	3vpy-assembly1.cif.gz_A Crystal structure of Arabidopsis DDL FHA domain	1.881E-03	1.000	112	312	442	443	15	137	145	147	0.296	0.848
LOKIASV2_0185_ESMFold_hypothetical_protein	2jpe-assembly1.cif.gz_A	2jpe-assembly1.cif.gz_A FHA domain of NIPP1	4.488E-03	1.000	106	313	436	443	26	129	132	127	0.280	0.788
LOKIASV2_0185_ESMFold_hypothetical_protein	7dco-assembly1.cif.gz_Y	7dco-assembly1.cif.gz_Y Cryo-EM structure of the activated spliceosome (Bact complex) at an atomic resolution of 2.5 angstrom	3.813E-03	0.999	97	302	436	443	44	174	174	155	0.305	0.753
LOKIASV2_0185_ESMFold_hypothetical_protein	5z57-assembly1.cif.gz_X	5z57-assembly1.cif.gz_X Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom	5.578E-03	0.998	95	289	437	443	38	157	158	156	0.336	0.759
LOKIASV2_0185_ESMFold_hypothetical_protein	2n84-assembly1.cif.gz_A	2n84-assembly1.cif.gz_A Solution structure of the FHA domain of TbPar42	4.251E-03	0.998	95	313	435	443	72	173	179	126	0.278	0.570
LOKIASV2_0185_ESMFold_hypothetical_protein	5z58-assembly1.cif.gz_X	5z58-assembly1.cif.gz_X Cryo-EM structure of a human activated spliceosome (early Bact) at 4.9 angstrom.	6.219E-03	0.996	90	289	437	443	38	157	158	156	0.336	0.759
LOKIASV2_0185_ESMFold_hypothetical_protein	5z56-assembly1.cif.gz_X	5z56-assembly1.cif.gz_X cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom.	9.098E-03	0.991	84	289	437	443	38	158	159	154	0.336	0.761
LOKIASV2_0185_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_A	2pu8-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	6.342E-04	0.981	79	20	295	443	19	372	373	388	0.623	0.949
LOKIASV2_0185_ESMFold_hypothetical_protein	3hue-assembly1.cif.gz_A	3hue-assembly1.cif.gz_A Structure of the S. pombe Nbs1 FHA-BRCT1-BRCT2 domains	1.305E-01	0.900	67	379	435	443	50	115	307	67	0.129	0.215
LOKIASV2_0185_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	1.713E-01	0.196	39	4	291	443	14	348	352	397	0.650	0.952
